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Abstract
Heart Failure is a growing and costly problem in the United States. There have been
advancements in medical therapy, but unfortunately patients continue to have frequent
exacerbations and hospital readmissions. The reason for this may be inadequate Heart
Failure self-care, which is the most important aspect of disease management. Literature
strongly encourages self-care, but there is minimal research focusing on the use of a
Heart Failure diary. The study was a one group pretest/posttest design. The intervention
included individualized education, provision of the Heart Failure Diary, and weekly
follow-up for a total of four weeks. The Heart Failure Diary was developed specifically
for this study for recording daily self-care maintenance activities which includes weight
monitoring, fluid intake, salt intake, swelling, shortness of breath, and medication
adherence. In order to determine the effects of using the diary on self-care and quality of
life, the Self-Care of Heart Failure Index (SCHFI) and Minnesota Living with Heart
Failure Questionnaire (MLHFQ) responses were compared pre and post intervention.
The difference between the SCHFI pretest-posttest scores demonstrated a non-significant
improvement in self-care maintenance, n = 14, 2.616 (12.942), SE = 3.459, p = .463, t = .756, 95% CI [-10.089, 4.856]. The difference between the MLHFQ pretest-posttest
scores demonstrated a non-significant improvement in quality of life, n = 14, -5.500
(18.851), SE = 5.038, p = .295, t = 1.092, 95% CI [-5.384, 16.384]. The effect size of the
SCHFI, d = .20, and the MLHFQ, d = .29, are both small and most likely due to the small
sample size. The study concluded that using the diary did not have a statistically
significant effect on the self-care or quality of life of these patients with heart failure.

Chapter One: Introduction
Heart failure (HF) is a common and increasing health problem worldwide. It is a
chronic illness that is associated with poor quality of life (QOL), frequent hospital
readmissions, and early death (Riegel & Dickson, 2008). Negative outcomes may be
averted through adherence to recommended treatment and recognizing worsening
symptoms. Self-care is essential for improving QOL for those with HF. The diagnosis of
heart failure requires a change of lifestyle in order to adhere to treatment. The change of
lifestyle involves daily weight monitoring, decreasing sodium intake, reducing fluid
intake, continuing exercise as tolerated, recognizing symptoms, administering
medications as prescribed, and following-up with health providers regularly. Self-care is
the sole responsibility of patients, although the support of family members and providers’
provides positive reinforcement and guidance.
Nurses play a major role in engaging and encouraging patients in performing selfcare. In most health care settings, nurses provide the majority of patient education.
Patient education is of great importance in order to assist patients in taking control and
adapting to their diagnosis of heart failure (Washburn & Hornberger, 2008). Heart
failure clinics, a setting that provides frequent patient-nurse interaction, have proven to
reduce hospitalizations (Eastwood, Travis, Morgenstern, & Donaho, 2007). Nurses
interact with patients to assess their needs, intervene appropriately, and evaluate their
outcome. Self-care activities may be demanding for some patients and therefore may
benefit from the support and encouragement nurses can provide. The self-care
collaboration of patients with nurses is important for illness adaptation, self-care success,
and quality of life improvement.
The American Heart Association (AHA) recommended HF self-care behaviors
include symptom monitoring (i.e., weight changes, shortness of breath, and swelling),
sodium restriction, and medication adherence (Riegel, Lee, Dickson, & Carlson , 2009).
These recommended behaviors were the focus of this study’s HF health diary entries.
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Problem and Purpose
According to Eastwood et al. (2007) heart failure programs commonly encourage
patients to record their daily weight and symptoms; but lack in description,
demonstration, and reinforcement. Literature strongly encourages self-care, but there is
minimal research focusing on the use of a HF health diary (Eastwood et al., 2007). Selfmonitoring may improve body awareness, communication with health professionals, and
self-efficacy in controlling heart failure. Diaries may be useful for nurses in assessing,
promoting, and evaluating self-care behaviors. The purpose of this study is to determine
the effects of using a HF diary on self-care and QOL. The study hypothesizes that the
use of a health diary will improve self-care and quality of life, in patients with heart
failure.
Conceptual Framework
Heart Failure Self-care. Riegel & Dickson’s (2008) article “A SituationSpecific Theory of Heart Failure Self-Care” provides a description and visual
presentation of the HF self-care process based on the natural decision making (NDM)
framework. The four characteristics of NDM include: “(1) focusing on process rather
than outcome, (2) using decision rules that match the situation and the action, (3) letting
context influence decision-making, (4) basing practical decisions on the empiric
information available at the moment” (Riegel et al., 2004, p. 351). It recognizes HF selfcare as a process that is initiated by self-care maintenance, transitions into action with
self-care management, and influenced by self-care confidence.
According to Riegel and Dickson’s (2008) theoretical model, the HF self-care
process is categorized into stages (see Figure 1). The first (i.e., symptom monitoring and
treatment adherence) and second (i.e., symptom recognition) stages constitute self-care
maintenance. The third (i.e., symptom evaluation), fourth (i.e., treatment
implementation), and fifth (i.e., treatment evaluation) stages constitute self-care
management. The theoretical model also illustrates the context of self-care confidence
and its role in the overall self-care process. The modifying effect of self-care confidence
on outcomes is two-fold, as a mediator or moderator (Riegel & Dickson, 2008).
Successful maintenance and management may improve confidence and vice versa.
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Self-Care of Heart Failure Model
Self-care Maintenance

Stage 1
Symptom monitoring and
treatment adherence

Stage 2
Symptom
Recognition

Self-care Management

Stage 3
Symptom
Evaluation

Stage 4
Treatment
Implementation

Stage 5
Treatment
Evaluation

Self-care Confidence
Figure 1. The theoretical model depicting the self-care process, for patients with Heart
Failure, with self-care maintenance as the study’s focus. Adapted from “A situationspecific theory of heart failure self-care,” by B. Riegel & V. Y. Dickson, 2008, Journal of
Cardiovascular Nursing, 23, p.192.
The situation-specific theory of heart failure self-care is an applicable framework
to integrate into this study. The theory’s conceptual design is congruent with this study’s
focus on self-care maintenance. The theory assumes and/or predicts that self-care
maintenance improves self-care management. In “Psychometric Testing of the Self-care
of Heart Failure Index” the authors hypothesized that the patients with inadequate
symptom recognition were unsuccessful in proceeding to the subsequent steps of self-care
management. The treatment initiation and treatment evaluation scores were significantly
higher in patients that recognized symptoms quickly (Riegel & Dickson, 2008).
Symptom recognition is essential in self-care management.
Quality of Life. A major goal of nursing is promoting self-care and improving
quality of life (QOL). In 1985, Padilla & Grant developed a QOL model that identifies
independent nursing process interventions as an individual concept (see Figure 2)
(Bredow, Peterson, & Sandau, 2009, Chapter 13, p. 279). The model recognizes self-care
promotion as a variable of the independent nursing process. Visually, it represents the
influence self-care promotion has on perceived self-care ability. Subsequently, perceived
self-care ability effects QOL dimensions, specifically diagnosis/treatment response and
physical wellbeing. The model was originally developed from cancer research, however
its self-care conceptual component may make it applicable to HF as well.
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Figure 2. Padilla & Grants’ theoretical model recognizes self-care promotion, as a
nursing intervention that influences a patient’s overall quality of life. Adapted from
“Health-Related Quality of Life,” by T. S. Bredow, S. J. Peterson, and K. E. Sandau,
2009, Middle Range Theories: Application to Nursing Research, Peterson, S. J. &
Bredow, T. S. (Eds.), Chapter 13, p. 279.

Definition of Terms
Heart Failure. Heart failure is characterized by two factors (a) a
pathophysiological state in which inadequate cardiac output is unable to meet metabolic
demands of tissues or (b) elevated intracardiac pressures deliver adequate cardiac output
but can precipitate systemic or vascular congestion (DiSalvo, 2005).
Self-care. Self-care is defined by Riegel and Dickson (2008) as “a naturalistic
decision-making process involving the choice of behaviors that maintain physiologic
stability (maintenance) and the response to symptoms when they occur (management)”
(p. 190). Self-care is composed of self-care maintenance and self-care management.
This process is further broken-down into the five stages included in the self-care of heart
failure theoretical model by Riegel and Dickson (2008).
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Self-care Maintenance. Self-care maintenance is defined by Riegel and Dickson
(2008) as “behavior used to maintain physiologic stability-symptom monitoring and
treatment adherence” (p. 192). It is the first stage of the self-care of heart failure Model,
to include treatment adherence and symptom monitoring. Heart failure self-care
maintenance activities include; medication adherence, low salt diet, exercises, engaging
in illness preventive behaviors, and monitoring for signs/symptoms (Riegel et al., 2009).
Self-care Management. The term is differentiated from self-monitoring by its
characteristics of adaptation to chronic condition(s), effective communication, selfefficacy, problem solving, and goal-setting (Wilde & Garvin, 2007). According to Riegel
& Dickson (2008), self-care management is the decision making process in response to
symptoms. It contains stages two to four of the self-care of heart failure Model. Stage
two is recognizing symptoms (e.g., weight gain and/or edema). Stage three is symptom
evaluation, during which the patient rationalizes why the symptom may have occurred
(e.g., increase in fluid and/or sodium intake). Stage four is treatment implementation, the
process a patient makes to treat a symptom appropriately (e.g., extra diuretic dose). Stage
five is treatment evaluation, a process of analyzing if the intervention was successful and
if not seeks help from a health professional. Consistent execution of self-care
maintenance and management may improve overall HF self-care.
Quality of Life. Quality of life is a broad theoretical concept with a multitude of
definitions. A definition of QOL is a sense of well-being, resulting from an individual’s
satisfaction or dissatisfaction with what they consider important in their life (Bredow et
al., 2009). QOL is a patient’s subjective perception of a disease’s effect on activities of
daily living (Chiaranai, 2007). Heart failure diagnosis can diminish QOL due to several
impairments caused or worsened by the disease (e.g., physical, socioeconomic, and
psychologic) (Blinderman, Homel, Billings, Portenoy, & Tennstedt, 2008). These factors
are components of Padilla & Grant’s QOL Conceptual Model (Bredow et al., 2009).
Health Diary. Health diaries are categorized into two types (e.g., ledger and
journal) (Eastwood et al., 2007). Ledger diaries are formatted to record data as they
occur. Journal formats require entries even when there is no event, but provides more
detailed information and useful in research (Eastwood et al., 2007). Successful heart
failure self-care can result in improved outcomes or quality of life. Tracy (1999) found
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that recording self-care behaviors in a diary format is associated with an enhanced quality
of life.
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Chapter Two: Review of Literature
This chapter will present an overview of HF including epidemiology,
pathophysiology, diagnosis, signs/symptoms, staging, and recommended therapy. Patient
education, nurse directed care, and self-care are major components of HF disease
management. Self-care is categorized into maintenance and management, with health
diaries as a tool to record activities. Improved quality of life is the goal of HF disease
management.
Heart Failure
Epidemiology. According to the “Heart Disease and Stroke Statistics-2010
Update” and data from the National Heart, Lung, and Blood Institute (NHLBI)
Framingham Heart Study, HF incidence is approaching 10 per 1000 individuals of the
population over the age of 65 years (AHA, 2010). By the age of 40 years, the risk for
developing HF is 1 in 5 for both men and women. In 2006 the prevalence of HF in adults
20 years and older was 5,800,000 individuals, with 3,100,00 males and 2,700,000
females. Diastolic HF is the most common cause HF in women, 40%-50% (Brashers,
2006). Individuals less than 65 years of age, 80% of men and 70% of women, will die
from HF eight years after diagnosis (AHA, 2009). Survival with heart failure beyond
five years is less than 50% (Chriss, Sheposh, Carlson, & Riegel, 2004). In 2006, in
regard to race and gender, the prevalence of HF in Black females was the highest at 3.6%
when compared to White males at 3.2%, Black males at 3.0%, White females at 2.1%,
Mexican American females at 1.8%, and Mexican American males at 1.7% (AHA, 2010).
Heart Failure hospitalization discharges continue to increase from 877,000 in
1996 to 1,106,000 in 2006. Exacerbation readmission within a 3-6 month period is
estimated to be 25% to 50% of discharged patients (Chriss et al., 2004). During 2006,
HF any mention mortality (i.e., mentioned in death certificates) was 282,754 deaths.
Heart failure was cited as the underlying cause in 60,337 of those deaths (AHA, 2010).
Heidenreich et al. (2011) estimates that more than 40% of the US adult population (i.e.
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116 million individuals) will have a form of cardiovascular disease, including HF, by the
year 2030.
Heart failure is a major contributor to the increasing costs of healthcare in the
United States. The estimated total cost of HF in the US was $37.2 billion in 2006 and
increased to $39.2 billion in 2010 (AHA, 2010). In the article “Forecasting the Future of
Cardiovascular Disease”, the projected cost of Cardiovascular Disease (CVD) in the
United States by 2030 is estimated to exceed $1 trillion (Heidenreich et al., 2011). The
United States’ direct medical cost of HF is projected to increase from $24.7 billion in
2010 to $77.7 billion in 2030. The indirect (i.e., loss of productivity) cost is projected to
increase from $9.7 billion in 2010 to $17.4 billion in 2030 (Heidenreich et al., 2011). HF
is a growing societal and financial burden in the U.S.
Pathophysiology. Heart failure is characterized by two factors (a) a
pathophysiological state in which inadequate cardiac output (CO) is unable to meet
metabolic demands of tissues, or (b) elevated intracardiac pressures deliver adequate
cardiac output but can precipitate systemic or vascular congestion (DiSalvo, 2005). The
most common cause of heart failure is left ventricular dysfunction. Heart failure is
categorized as either systolic or diastolic.
Systolic Heart Failure. Systolic heart failure is defined by a reduction in left
ventricular contractility, unable to deliver adequate cardiac output, to adequately perfuse
tissues with vital oxygen and metabolites (Brashers, 2006). Myocardial infarction (MI) is
the most common cause of reducing left ventricular contractility. Systolic heart failure is
characterized by an increase in ventricular preload, end volumetric pressure, and
afterload, pressure required for ejection.
Increased preload stretches the myocardium, weakens contractility, and decreases
cardiac output. Reduced left ventricular contractility affects preload by decreasing
volume of blood ejected during systole (i.e., stroke volume), increasing plasma volume
left in the ventricle at the end of diastole (i.e., preload), and dilating the left ventricle
(Brashers, 2006).
According to Brashers (2006), increased afterload is a result of an increase in
peripheral vascular resistance (PVR) commonly due to hypertension (HTN) and valvular
diseases. The process begins with (a) an increase in PVR causing resistance to left
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ventricular emptying, (b) the workload is increased, (c) the myocardium remodels and
becomes hypertrophied, (d) increase in oxygen demand increases, (e) collagen
accumulates between myocytes (i.e., cardiac muscle cells), (f) integrity of the cardiac
muscle is damaged, (g) cardiac contractility weakens, (h) the ventricle becomes dilated,
and ultimately (i) Heart Failure. The end result of increased afterload causes a decrease
in cardiac output, therefore HF.
The multiple effects of a decreased CO further complicates heart failure.
Decreased renal perfusion activates the renin angiotensin aldosterone (RAA) system to
increase PVR and plasma volume (Brashers, 2006). This increases preload and afterload
and further complicates heart failure. The decrease in tissue perfusion activates
baroreceptors that (a) activate the sympathetic nervous system to cause vasoconstriction
and, (b) stimulation of the hypothalamus to produce antidiuretic hormone (ADH). ADH
increases water reabsorption from the kidneys, expands plasma volume, and ultimately
worsens heart failure. A decrease in CO activates neurohormonal and inflammatory
systems resulting in apoptosis (e.g., cell death), myocardial remodeling, arrhythmias, and
fluid retention. Heart Failure consists of multiple harmful pathophysiologic events that
worsen the already complicated disease process (Brashers, 2006).
Diastolic Heart Failure. Diastolic HF can occur in conjunction with systolic HF
or independently (Brashers, 2006). Diastolic HF is characterized by the presence of
pulmonary congestion even with adequate CO and normal stroke volume. Diastolic
failure results from decreased compliance of the left ventricle and abnormal diastolic
relaxation. Decreased compliance of the left ventricle causes a usually normal preload
volume to increase left ventricular end-diastolic pressure (LVEDP). The pressure is
reverted back to the pulmonary vasculature, therefore causing pulmonary congestion.
Diastolic HF is caused by hypertension induced cardiomyopathy, valvular disease, and
MI that results in remodeling. Diabetes increases the risk for developing diastolic HF
(Brashers, 2006).
Diagnosis. The most commonly used diagnostic test in evaluating patients for
heart failure is the comprehensive 2-dimensional echocardiogram with doppler flow
studies (AHA, 2009). The test is used to determine the presence of abnormalities in the
myocardium, heart valves, or pericardium. AHA guidelines state that it is important for

10
the provider to assess if the left ventricle ejection fraction (LVEF) is preserved or
reduced, normal/abnormal structure of left ventricle, and presence/absence of other
structural abnormalities. The echocardiogram is important in evaluating heart failure and
may serve as a baseline for comparison, when there are changes in patient status.
Brain natriuretic peptide (BNP) levels are increased in heart failure and found to
decrease preload (Brashers, 2006). Studies have shown that BNP levels are parallel to
severity of HF (AHA, 2009). BNP levels are elevated in those with reduced LVEF, LV
hypertrophy, elevated LV filling pressure, acute MI, and ischemia. Patients with
symptomatic heart failure present with an elevated BNP level, therefore the lab test is
useful in determining HF as the cause of dyspnea instead of other causes (e.g., chronic
pulmonary disease, renal failure, hepatic failure).
Signs and Symptoms. Heart failure is characterized by a combination of signs
symptoms that may differ with each patient. HF symptoms include exertional dyspnea,
orthopnea, paroxysmal nocturnal dyspnea, elevated jugular venous pressure, pulmonary
rales, third heart sound (i.e., S3), and peripheral edema (DiSalvo, 2005). Other chronic
conditions may present similarly to HF, therefore diagnosis may be differentiated with
BNP levels and an echocardiogram. Medications and lifestyle changes (e.g., self-care)
are geared to decrease symptom effects and increase functioning in activities of daily
living (ADL). The main goal of treatment is improving QOL.
The New York Heart Association (NYHA) Heart Failure Symptom Classification
System is subjective, but widely accepted by healthcare providers (AHA, 2009). The
purpose of the classification is to assess severity of functional limitations and correlates
with prognosis. The four classification levels are (a) NYHA class I, no symptom
limitation and ordinary physical activity; (b) NYHA class II, ordinary physical activity
limited by dyspnea; (c) NYHA class III, moderate exercise limited by dyspnea; and (d)
NYHA class IV, dyspnea at rest or with little exertion.
According to the AHA (2009), patients with LV dysfunction usually present with
HF in three ways. First, decreased exercise tolerance. Usually patients seek medical
attention complaining of dyspnea and/or fatigue with ADL. Patients and/or healthcare
providers may attribute these symptoms with aging, other physiological abnormalities
(e.g., de-conditioning from inactivity), or other medical disorders (e.g., pulmonary
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disease). It is important to distinguish HF or another condition as the cause of symptoms.
Second, patients may present with fluid retention (e.g., swelling of lower extremities
and/or abdomen). Third, patients may exhibit cardiac enlargement or dysfunction after
being evaluated for HTN, abnormal chest x-ray, arrhythmia, or acute MI (AHA, 2009).
Weight gain is a sign of decompensating HF (Chaudhry, Wang, Concato, Gill, &
Krumholz, 2007). The goal of the authors’ study was to identify weight gain as a trend
that preceded hospitalization and as a risk factor for imminent hospitalization. The
research was an 18 months case-control study that used data from an electronic home
monitoring system to transmit weight to a database monitored by nurses. The case study
group included 134 patients with HF hospitalization and the control group included 134
patients without hospitalization. The patients were instructed to weigh themselves daily.
A gain of at least five pounds, in three days, was automatically reported by fax to the
patient’s physician. The physicians then decided on appropriate intervention(s) or change
in therapy. In the case group, the study found that a trend in weight gain started about a
week before hospital admission. The control group retained a stable weight. Daily
weight trends within 30 days pre-hospitalization were statistically significant (p <0.001).
Adjusted for comorbid conditions, the study results for heart failure hospitalizations were
(a) weight gain greater than two and up to five pounds were associated with an adjusted
matched OR of 2.77 (95% CI [1.13-6.80]), (b) weight gain greater than five and up to ten
pounds with adjusted matched OR = 4.46, 95% CI [1.45-13.75], and (c) weight gain
greater than ten pounds with adjusted matched OR = 7.65, 95% CI [2.22-26.39]. Higher
amounts of weight gain were strongly associated with increasing the risk for
hospitalization. In summary, weight gain can increase the risk for hospitalization and
evident at least one week prior. Healthcare providers’ awareness of a patient’s change in
status (e.g., weight gain) indicates an opportunity for clinicians to intervene (e.g.,
increase diuretic dosage). Early detection and intervention may avoid exacerbation and
hospitalization (Chaudhry et al., 2007).
Staging and Recommended Therapy. The American College of Cardiology
Foundation (ACCF)/American Heart Association (AHA) “Guidelines for Diagnosis and
Management of Heart Failure in Adults” divided the disease process into four stages of
development (see Figure 3). The guidelines serve to define practice and provide quality
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care. However, each patient is unique and there may be situations that require deviation
from the guidelines. The physician and patient must collaborate on an appropriate
treatment plan. Stages A and B include patients at high risk for developing HF. Stages C
and D includes the patients already diagnosed with HF.

Figure 3. Heart Failure staging and recommended therapy. Adapted from “2009
Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and
Management of Heart Failure in Adults”, by AHA, 2009, Circulation, 119, p. 398.
Copyright 2009 by the American Heart Association.

Stage A. Stage A includes individuals at high risk for HF, but asymptomatic
and without structural heart disease (AHA, 2009). The risk factors are atherosclerotic
disease, diabetes, obesity, metabolic syndrome, cardiotoxins (e.g., cocaine), and family
history of cardiomyopathy. Hypertension remains to be the most common risk factor for
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heart failure. In fact, 75% of patients diagnosed with heart failure had a history of
hypertension. The risk is double for people with an average blood pressure (BP) greater
than 160/90 mmHg compared to those with a BP less than 140/90 mmHg. The AHA
recommended management strategies include hypertension treatment, encouraging
smoking cessation, treating lipid disorders, exercising regularly, controlling metabolic
syndrome, discouraging alcohol consumption, and deterring from illicit drug use.
Medical therapy should include angiotensin converting enzyme inhibitor (ACEI) or
angiotensin II receptor blocker (ARB) (AHA, 2009).
Stage B. Stage B is characterized by the presence of structural heart disease, but
absent of HF symptoms (AHA, 2009). These patients include those with a medical
history of previous MI, left ventricular remodeling with a low ejection fraction, and
asymptomatic valve disease. Recommended management is similar to Stage A. Medical
therapy includes ACEI or ARB plus a beta-blocker. According to the AHA, implantable
defibrillators are recommended for selected patients at high risk for deadly arrhythmias.
Stage C. Stage C includes patients with known structural heart disease and
symptoms of heart failure (e.g., fatigue, activity intolerance, and shortness of breath)
(AHA, 2009). Therapy goals include a low sodium diet in addition to Stage A and B
regimen. Medical therapy includes beta-blockers, diuretics, ACEI and/or ARB. Selected
patients will also be prescribed aldosterone antagonist (e.g., spironolactone), Digoxin,
Hydralazine, and/or Nitrates. Implantable cardiac defibrillators (ICD) are recommended
for those at high risk for arrhythmias.
For some patients in stage C, a combination of an ICD and Cardiac
resynchronization therapy (CRT) device is recommended. A CRT device electrically
stimulates the contraction of the ventricles in a synchronized manner, via biventricular
pacemaker. According to the AHA (2009) the CRT has shown to enhance ventricular
contraction, reduce mitral regurgitation, and improve hemodynamics without increasing
oxygen demand. CRT devices reduce heart failure admissions by 32% and mortality by
25%. The device also decreases hospital readmissions for patients with persistent
symptomatic HF. The AHA states that there is strong evidence that CRT improves
symptoms, exercise capacity, QOL, LVEF, and survival.
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Stage D. Stage D is defined as heart failure refractory to maximum medical
treatment and require specialized interventions (AHA, 2009). Patients are symptomatic
even at rest, have profound fatigue, unable to perform ADL, and cannot be safely
discharged from the hospital. These patients are noted for frequent and/or prolonged
hospitalizations. Therapy goals include measures in Stage A, B, and C. Decisions in
regard to end-life care (i.e., hospice) need to be discussed with the patient and their
family. Extraordinary treatment options include heart transplant, chronic inotropes,
permanent mechanical support, and experimental surgery/drugs (AHA, 2009).
A controversial treatment is intermittent intravenous positive inotropic therapy
(e.g., dobutamine and milrinone) administered in outpatient clinical settings (e.g., heart
failure clinic) or at home (e.g., home health care). Positive inotropes act to increase
contractility and increase CO (Petersen & Felker, 2008). The harmful effects include
increase in oxygen demand and arrhythmias, therefore not indicated for short or long
term therapy. According to the AHA (2009), long-term oral inotropic therapy has shown
to increase mortality significantly and does not improve clinical status or symptoms. The
AHA states that the only benefit associated with intermittent inotropic treatment in the
outpatient setting results from the increased surveillance by healthcare providers. The
AFFC/AHA does not recommend intermittent infusion of positive inotropic agent for
long-term treatment of HF, even in advanced stages. However, continuous positive
inotropic agents (e.g., dobutamine, dopamine, and milrinone) are sometimes administered
as palliative treatment to allow patients to die in comfort (AHA, 2009).
Disease Management
The Cochrane Review “Clinical Service Organisation for Heart Failure
(Review)” states that traditionally, HF management emphasized only acute care.
However, HF management is now evolving its focus towards more proactive and
preventive disease management models (Taylor et al., 2009). The three types of HF
disease management models include (a) multidisciplinary, (b) case management, and (c)
clinic. Multidisciplinary models offer a holistic approach in managing HF. The
multidisciplinary team involves different professions (e.g., medical, psychosocial,
behavioral, and financial) working in collaboration. Case management models are
characterized by intense monitoring of patients post-discharge. Case management is
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conducted by a nurse and involves home visits and/or telephone calls. The clinic models
include outpatient clinics run by cardiologists or nurses guided by protocol. Only one
multidisciplinary intervention study was included in the review. The multidisciplinary
models resulted in preventing hospital readmissions in the short term. Only two clinic
interventions studies were included in the review, but they lacked statistical power and no
evidence of any benefit. The review found that case management models reduced all
cause mortality, from the analysis of better quality studies, OR 0.68, 95% CI [0.46-0.98,
p = .04. Some case management interventions supplied patients with diaries and charts
for recording self-care maintenance (Taylor et al., 2009).
Participation in HF disease management programs have shown to improve
functional status, improve quality of life, and reduce hospital admissions due to
exacerbations (Rockwell & Riegel, 2001). Post-discharge support has shown to reduce
readmission rates, improve health outcomes, and enhance QOL. Studies show that a onehour session of patient education from a nurse educator improved clinical outcomes,
reduced costs, and increased treatment adherence (Rockwell & Riegel, 2001). The
ACCF/AHA management guidelines state that patient education and close supervision
improves treatment adherence (AHA, 2009). Performing self-care leads to early
detection of symptoms, allowing the patients and/or healthcare providers to initiate
treatments that prevent exacerbations. According to the guidelines, nurses with special
training in HF are sufficient in supervising patients’ self-care and the presence of a
physician is not required (AHA, 2009).
Patient Education. Nurses are the key providers of patient education
(Washburn & Hornberger, 2008). Heart Failure self-care education has proven to
decrease hospital readmission rates, lower risk for death, and decrease costs of care
(AHA, 2009). Patient education topics include symptoms of HF, weight management,
dietary recommendations, medications, and exercise (Washburn & Hornberger, 2008).
Symptom recognition is an important step in the HF self-care process. Weight gain
usually precedes hospitalization, recognizing these trends can prevent exacerbations
through a change in treatment (Chaudhry et al., 2007). A sodium-restricted diet is
standard for HF patients. Patients should be made cautious of salt substitutes because
they are potassium based and can affect medications. Reading food labels and avoiding
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high sodium foods (e.g., canned and frozen foods) should be recommended. Patients
should be taught medication action, dosage, frequency, and side effects. They should
also be encouraged to bring a list of all their medications to physician visits. Patients
should be warned against non-steroidal anti-inflammatory drugs (NSAID) because they
interfere with medical therapy. Exercise should be encouraged because it has proven to
improve symptoms, QOL, balance, and functional capacity.
The ACCF/AHA guidelines state that written instructions must be given to
patients at discharge and include: activity level, diet, discharge medications, follow-up
appointment, weight monitoring, and symptom interventions (AHA, 2009). Health care
providers cannot assume that written patient education alone promotes self-care.
According to the study “Factors Influencing Knowledge of and Adherence to Self-care
Among Patients with Heart Failure” 37% of 113 patients reported they knew “little or
nothing” after receiving written and verbal heart failure education (Ni et al., 1999). In
order to adequately teach self-care activities, nurses should take time to understand each
patient’s ability to learn and perform necessary behaviors (Rockwell & Riegel, 2001).
Importantly, patient education should be individualized due to the variability of each
patient’s self-care abilities.
Nurse Directed Care. A study by Kutzleb & Reiner (2006) found that nurse
directed and focused interventions significantly improves QOL. The authors carried out
a quantitative quasi-experimental design comparing nurse-directed care (NC) and routine
care medical management (RC). A cardiologist and cardiac nurse specialist managed the
NC group. A cardiologist and cardiology fellows managed the RC group. The clinical
nurse specialist performed physical examination, initiated prescribed medical therapy,
and provided an individualized educational plan. Patients in the NC group were provided
a calendar to document daily weight. The RC group was provided counseling on topics
of smoking cessation, medications, and nutrition. NC group interventions were
monitored by telephone follow-up and the RC group was not. The results show that 80%
of the RC group reported never being placed on or did not follow the recommended diet.
The RC group also had lower adherence to medications. Eighty-four percent of the NC
group actively engaged in exercise, compared to 40% for the RC group. For the NC
group there was an overall and significant improvement in QOL, F(5, 63) =13.569, p =

17
.0000. The NC group described that their ability to manage diet and medications was the
most positive change in their quality of life (Kutzleb & Reiner).
The study concluded that nurse directed focused interventions reinforced
diligent self-care maintenance, improved QOL, and treatment adherence (Kutzleb &
Reiner, 2006). The nurse directed care interventions improved the QOL of patients with
HF. This was the basis for including individualized education, weekly follow-up for a
period of four weeks, and a health diary into this study. Nurse directed care provides
added benefits when added to the traditional medical management.
Self-Care. According to ACCF/AHA guidelines, close observation and followup is the most effective and unfortunately least used measure in HF management (AHA,
2009). The treatment of HF is only effective with active self-care participation and
treatment adherence, therefore health care providers should make every effort to
encourage and engage them. Patients with heart failure are responsible for the majority
of their care including medication adherence, daily weight monitoring, low
sodium/cholesterol diet, limiting fluid intake, and exercising as tolerated. Noncompliance with prescribed medications and sodium/fluid restriction is a common factor
in precipitating hospitalization. Increases in body weight and minor symptoms occur
several days prior to severe clinical episodes that require hospitalization (Chaudhry et al.,
2007).
A non-experimental correlational study by Rockwell & Riegel (2001) analyzed
predictors of self-care in persons with heart failure. The authors hypothesized that
severity of symptoms, comorbidity, social support, education level, age, socioeconomic
level, and gender are predictors of heart failure self-care. The study found only two of
the variables to have strong significance in predicting self-care, educational level and
severity of symptoms. Patients with higher education were associated with treatment
compliance and healthy behaviors. However, they recognized that a person with lower
education level can learn self-care, but needs more time to be taught the process. Patients
with severe symptoms were found to have high self-care scores. Having experienced
frequent exacerbations, these patients became experts in recognizing severe symptoms
and actively participated in self-care. Personal experience with exacerbations contributes
to symptom recognition and motivates self-care. On the contrary, individuals with mild

18
HF may have difficulty in recognizing symptoms and understanding the purpose for selfcare (Rockwell & Riegel, 2001).
According to Rockwell and Riegel (2001), self-care behaviors require patients to
make reasonable, knowledgeable, and thoughtful judgments about symptoms and
response to treatment. The authors describe self-care as an active and cognitive process,
that patients engage in for the purpose of maintaining health or managing illness. Poor
self-care is associated with poor outcomes in HF. Those who do not actively participate
in self-care are frequently readmitted to the hospital (Chriss et al., 2004).
Self-care Maintenance. Many signs of heart failure decompensation can be
anticipated with self-care maintenance. Self-care maintenance involves the symptom
monitoring and treatment adherence stages of the self-care of heart failure model (Riegel
& Dickson, 2008). Monitoring involves measuring, recording, and observing for
symptoms. The heart failure disease process requires patients to maintain a balance
between physiologic compensation and decompensation. Subtle symptom awareness is
very important and is achieved through diligent recording of symptoms (e.g., weight gain,
edema, shortness of breath, fatigue). Self-care maintenance is linked to improving body
awareness, communication with healthcare providers, and sense of empowerment in
controlling disease process (Eastwood et al., 2007).
There are multiple factors that influence self-care maintenance. Patients with
comorbid conditions show to have a lower level of self-care performance (Chiaranai,
2007). The author observed that a higher level of education and strong social support
positively influenced self-care behavior. Chris et al. (2004) found that higher education
does not predict level of self-care maintenance. The author concluded that older male
patients had better self-care maintenance and attributed it to their satisfaction with
independent problem solving of health issues (Chris et al., 2004).
Adequate self-care maintenance is very important in the management of HF.
Benefits include the improvement of body awareness, sense of empowerment, and
communication with providers and caregivers. Self-care maintenance activities of
patients with HF include medication adherence, daily weight monitoring, dietary
restrictions, limiting fluid intake, and exercise. With some similarity to overall self-care,
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factors that may affect self-care maintenance include comorbidities, educational level,
age, gender, and social support. Health diaries are tools for maintaining self-care.
Health Diary. A majority of the elderly population has been diagnosed with a
chronic disease and may experience symptoms on a daily basis. Historically, prospective
diaries have been used in research data collection since the 1950’s and continue to be
used in nursing studies (Aroian & Vander Wal, 2007). Perceived symptom experiences
is the most important factor in determining whether elderly individuals will partake in
self-care or seek medical care. The possible drawbacks of daily diaries they may be
viewed as burdensome, timely, and chronic illness symptoms may be overlooked due to
acclimation. There is very little information in the literature on the number of diary days
necessary to produce sufficient research data. Aroian & Vander Wal (2007) performed a
methodological study investigating the utilization of a seven days prospective symptoms
diary and retrospective symptom report (RSR) in a community-dwelling elderly
population. The research questions were (a) whether a 7 day daily symptom diary
yielded any new information from the first diary day, (b) degree of comparability of
experiences with prospective daily symptom diary with RSR, (c) which of the two
methods (e.g., daily diary or retrospective reports) produced data more consistent with
reports of functional health status. The research findings concluded that (a) the total
number of symptoms reported on each day of the daily diary declined, F(6, 214) = 13.51,
p< .0001 (b) 82.7% of symptoms reported on the first diary day was also reported on
subsequent diary day, (b) the majority of symptoms were endorsed more frequently with
RSR. The study results concluded that RSR had a strong significant correlation to
physical, r = -0.51, p < .0001 and mental, r = -0.40, p < .0001, health summary scores of
functional health status. Daily diary use had a lower significant correlation to physical, r
= - 0.43, p < .0001 and mental, r = - 0.31, p < .001 health summary scores of the
functional health status. However, the difference between the RSR and daily diary was
not statistically significant, physical, t(304) = 1.62, p = ns and mental, t(304) = 1.90, p =
ns. According to the authors, a major limitation of the study is the daily diary may have
played a major role in causing the participants to be more sensitive to and have better
recall of symptom experiences to complete the RSR. Other study limitations include the
failure of acquiring RSR before and after daily diary use. Aroian & Vander Wal (2007)

20
suggest that daily diaries use may be appropriate for recording time-series data, for
example monitoring the progression of symptoms over time.
Eastwood et al. (2007) performed a retrospective descriptive study on the effects
of using a heart failure health diary on clinical and hospital outcomes. Prior to Eastwood
et al.’s 2007 research, only one study focused on HF diary use and found users to be on
more recommended medications, likely to attend education classes (e.g., HF clinics or
primary care visits), experience less symptoms, and associated with lower mortality rates.
The non-randomized sample included participants of a HF clinic whom were given the
option to use the Heart Health Diary, developed by the researchers. The sample
characteristics were patients classified as NYHA II-IV Class and had difficulty adhering
to treatment. The mean age of diary users were 65 years (+ 11.9 years), 50 men, and 42
women. The mean age of diary non-users were 56.7 (15.4) years, 32 men, and 22
women. NYHA classification and BNP levels were not significantly different between
the groups. Diary users contacted healthcare providers 35% more than non-users. Diary
user attended the clinic 47% more than non-users. Six months after the intervention,
ejection fraction improved in diary users, n = 50, from 27% (11.2%) to 29.3% (14.2%).
There was no change in the LVEF for diary non-users. NYHA and BNP levels improved
significantly for both groups, the authors recognized this as may be a result from their HF
clinic attendance. Hospital admission, showed no significant difference between groups.
Length of stay was decreased more significantly in diary users from 9.8 (9.5) to 4.1 (6.3)
days. Eastwood et al. (2007) found diary users to have better outcomes than non-users.
A study “Improving Heart Failure Symptom Recognition: A Diary Analysis”
aimed to determine patient adherence to daily weight monitoring, identify reasons for
non-adherence, determine the prevalence of > 3lbs in 1 day, and ascertain the frequency
participants sought medical advice for weight gain of > 3lbs (White, Howie-Esquivel, &
Caldwell, 2010). The study provided patients with a daily diary. The diary was for
weight and symptom monitoring. The study was a randomized 2-group experimental
design, intervention group (n=20) and care as usual group (n=16). Patient education and
counseling was provided to all participants. The intervention group was given a three
month daily diary to record daily weight, symptoms, unplanned hospital visits, and
physician contacts. Symptoms to be recorded on the diary included swollen ankles,
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swollen hands, weight gain, shortness of breath, and reduced exercise capacity. Sixteen
of the total 20 patients from the intervention group completed their diaries. The study
resulted in 79.4% of participants adhering to daily weight monitoring. Reasons for nonadherence included vacation, holiday meals, and forgetfulness. A total of 75% had a
weight gain of > 3lbs in one day. Only one participant contacted their physician for a
weight gain > 3lbs. Although the study was of a small sample size, it concluded that
adherence to daily weight monitoring may be achieved when incorporated with patient
education and utilization of diaries (White et al., 2010).
There were few studies in the literature review that incorporated health diaries in
the intervention or the number of diary days necessary to produce sufficient research
data. Diary use was found to have many benefits including improving adherence,
monitoring trends, decreasing length of hospital stay, and improving ejection fraction.
Factors affecting the use of diaries included age and educational level, which similarly
affects self-care. The drawbacks of diaries are that they may be viewed as timely or
burdensome. Reasons for non-adherence include holidays, vacations, and forgetfulness.
These are similar reasons why even healthy individuals derail from their health plan.
Self-Care Management. Self-care management encompasses stages two to five
of the self-care of heart failure model: (1) symptom monitoring and treatment adherence,
(2) symptom recognition, (3) symptom evaluation, (4) treatment implementation, and (5)
treatment evaluation (Riegel & Dickson, 2008). Preventing decompensation by
responding to symptoms is the goal of self-management (Chriss et al., 2004).
Symptom recognition is important for patients because early signs can be subtle,
but will progress to an exacerbation if left untreated. An important factor in HF self-care
is properly recognizing symptoms, initiating an appropriate course of action, and
evaluating its effect on symptom relief (Chriss et al., 2004). An understanding of the
symptoms, treatments, and overall heart failure self-care will positively affect the
patients’ symptom awareness and response (Chiaranai, 2007).
Chiaranai (2007) found that younger women responded quickly to symptoms
and performed appropriate self-care management than older women. This may be
attributed to difference in age, memory, motor response times, and problem solving
skills. Individuals with lower income were shown to also respond more quickly than
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those with a higher income. The author suggests that this may be to avoid expenses and
economic burden (e.g., hospital costs). Adequate level of self-management may result in
fewer symptoms, better functional capacity, and improved quality of life (Chiaranai,
2007).
A study by Gallagher, Donoghue, Chenoweth, & Stein-Parbury (2008) identified
six predictors of self-management in chronic illness as (a) the primary diagnosis, (b)
length of time diagnosed, (c) age, (d) sense of coherence (SOC), (e) self-perceived health,
and (f) self-efficacy. Sense of coherence is defined as “a pervasive feeling of confidence
that life and life’s demands are comprehensible, meaningful, and manageable” (Gallagher
et al., 2008, p. 374). Primary chronic illness diagnosis included in the study included HF,
chronic respiratory disease, Parkinson’s, and Schizophrenia. The Partners in Health
Scale instrument was used to measure self-management. The tool used a Likert scale to
rate self-management by primary diagnosis from very good (0) to very poor (88).
Schizophrenia associated with very poor self-care, Parkinson’s second, and HF third.
Mean self-management scores for patients with HF was 19.67 (13.68), p < .000, ranking
third after Schizophrenia and Parkinson’s disease (Gallagher et al., 2008). Correlates of
poor self-management include (a) elderly patients with low perceived health, (b) recent
diagnosis, (c) low SOC scores, and (d) worse self-efficacy scores. The study concluded
that the type of primary diagnosis was a strong predictor of self-management. However,
longer length of illness improved self-management (Gallagher et al., 2008).
Self-care management differs from self-care maintenance in that it is the process
one recognizes and analyzes symptoms, implements a plan of action, and evaluates the
effectiveness. Factors affecting management includes length of diagnosis, age, gender,
and socioeconomic status. The psychological factors that may affect HF self-care
management include self-confidence, self-perceived health, and self-efficacy. The
adequacy of self-care management activities is of great influence in determining a
positive or negative outcome. The ultimate goal in HF management is improving the
QOL of patients.
Measuring Self-Care. The Self Care of Heart Failure Index (SCHFI) was used in
this study to measure self-care adequacy. The SCHFI is based on Riegel & Dickson’s
(2008) theoretical model of HF self-care.
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Reliability. According to Riegel et al. (2009), a prospective study of communitydwelling patients, n = 154 with HF was used to determine the SCHFI reliability. The
subscales of the SCHFI have a coefficient alpha for self-care maintenance, n = 154, α =
.553, 95% CI [.439, .542]; self-care management, n = 73, α = .597, 95% CI [.434, .590];
and self-care confidence, n = 154, α = .828, 95% CI [.781, .836]. The developers
expected a low internal consistency of the self-care maintenance subscale because it
reflects a wide variety of behaviors and lifestyle changes that may have little association
with each other (e.g., exercise and medication adherence). There were significant
differences in each individuals responses as depicted in the variance of mean values of
the maintenance subscale, F = 122.45, p < .001; management subscale, F = 3.71, p <
.001; and confidence subscale, F = 20.58, p = .001. The individual self-care
maintenance, self-care management, and self-care confidence scales were not highly
intercorrelated, with no r = > .43, indicating that it measures the subscales as individual
constructs and therefore should be scored separately (Riegel et al., 2009).
According to Riegel et al. (2009), there was no learning effect, with minimal
changes in scores over time. The difference in scores was not statistically different. The
learning effect was assessed through comparison of baseline values to patient responses
one and two months later. The mean score at baseline was, 70.49 (14.32), n = 130; after
one month, 68.40 (16.61), r = 0.443, p = < 0.01, n = 130; and after two months, 69.66
(15.06), r = 0.470, p = <0.01, n = 110. The SCHFI scores when compared with the
Social Desirability Scale score did not result in any significant correlation, with self-care
confidence having the highest, n = 33, r = .32, p = .07 (Riegel et al., 2009).
Validity. According to Riegel et al. (2009), the validity of the SCHFI was
assessed qualitatively and quantitatively. Validity was assessed with two separate
studies, through which researchers compared qualitative with quantitative data (i.e.,
SCHFI). The first study, of which self-care adequacy was derived from nurse-patient
dialogue, resulted in low congruence between qualitative and quantitative data. The
second study consisting of a semi-structured interview guide classified participants as
poor, good, or expert in HF self-care. This study resulted in a parallel increase between
SCHFI scores and expertise: self-care maintenance score mean compared to poor, 70
(16.9), good 80 (12.2), and expert, 85 (5.0) (Riegel et al., 2009).
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The European Heart Failure Self-Care Behavior scale is a 5-point Likert scale
measuring self-care maintenance and was used in comparison to the SCHFI to test
concurrent validity (Riegel et al., 2009). The two questionnaires resulted in a moderate
correlation, r = .65, p < .001. Riegel et al. (2009) found the overall model fit of the
SCHFI as adequate, x2 = 356.92.
Construct validity testing used confirmatory factor analysis to determine whether
the SCHFI appropriately measured each subscale’s constructs (i.e., maintenance,
management, and confidence). From a sample of 154 patients, the study concluded that
maintenance correlated with confidence, which itself correlated with management (Riegel
et al., 2009).
Scoring. It was recommended by Riegel et al. (2009) to analyze each section
separately. The self-care maintenance subscale (i.e., Section A) of the SCHFI was used,
which is the study’s focus. It is a Likert scale format with the frequency of self-care
maintenance activities ranging from: 1 (i.e., never or rarely), 2 (i.e., sometimes), 3 (i.e.,
frequently), and 4 (i.e., always or daily). The self-care maintenance scale score ranges
from 10-40, this is then standardized to a range of 0 to 100. The standardized score is
calculated by the formula (sum of Section A items – 10)3.333. A score of greater than
70, demonstrates self-care adequacy. Question 5 (i.e., forget to take one of your
medicines), is a reverse scored item which may make the investigator’s calculation or
patients’ ability to respond appropriately complicated.
Summary. The medical treatment of HF is only effective if the patients are
actively partaking in their own self-care. Benefits of adequate self-care include early
detection that allows the patients and/or providers to initiate treatments in order to avoid
exacerbations. Studies have shown that worsening symptoms occur days before they
become severe enough to require hospitalization. Factors affecting self-care adequacy
include education and symptom severity. Higher education was associated with
compliance and healthier behaviors. More severe symptoms were easier to recognize
versus milder symptoms, and therefore these patients were found to have higher self-care
compliance. Utilizing tools that measure self-care adequacy, such as the SCHFI, may be
beneficial for patients and providers in monitoring health status. As providers, our role is
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in encouraging and engaging our patients to be active in their self-care. Even with an
adequate support system, it really comes down to the patients themselves.
Quality of Life
Several factors affecting the QOL for patients with HF include health status (i.e.,
symptoms related to illness), functional capacity, demographic factors (e.g., age), and
psychological state (Blinderman et al., 2008). These factors impact an individual’s
ability to function in everyday life and adapt to illness.
Heart failure symptoms (e.g., dyspnea and fatigue) can limit ADL functioning
(Rector, Anand, & Cohn, 2006). Blinderman et al. (2008) studied the effect of HF
symptom distress on QOL. There was a very strong correlation between symptom
distress and QOL, r = -0.74, p < 0.001. The four most prevalent symptoms were lacking
energy, dry mouth, shortness of breath, and feeling drowsy. Additional factors that
impaired QOL include comorbidities r = -0.32, p = 0.002; female gender, r = -0.22, p =
0.03; and functional capacity as measured by Sickness Impact Profile (SIP).
Psychological factors, r = -0.55, p < 0.001, compared to physical dysfunction, r =-0.41, p
< 0.001, showed greater association with QOL. Psychological well-being had a positive
impact on quality of life, r = 0.68, p <0.001. In summary, impaired function capacity
adversely effects QOL, but psychological factors is shown to be a strong influence as
well (Blinderman et al., 2008).
Chiaranai (2007) studied the relationship between self-care and QOL. The study
was based on the self-care of heart failure model developed by Riegel et al. (2004).
Chiaranai (2007) performed a non-experimental study measuring the relationships
between self-care strategies and QOL. Lower NYHA classification, fewer comorbid
diseases, fewer symptoms and younger age were found to correlate with an enhanced
quality of life. The study resulted in identifying self-care management as the best
predictor for disease-specific QOL. The author found that QOL was not influenced by
self-care maintenance, although QOL was associated with overall self-care performance
(Chiaranai, 2007).
Rector et al. (2006) studied the relationship between clinical assessments and
patients’ perceptions on QOL. The authors performed secondary analysis of data from a
previous multicenter, randomized, placebo-controlled, and double blind study of
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Valsartan (i.e., Valsartan Heart Failure Trial). Higher NYHA classification associated
with worsening MLHF QOL scores. Fatigue was found to vary MLHF scores by 38%
and NYHFA classification by only 19%. Patients’ age >65 years varied the scores by
4.5%. Patients’ jugular vein distention (JVD), EF, and BNP values were not shown to
affect QOL scores. Common symptoms (e.g., peripheral edema, pulmonary rales, and
JVD) accounted for 40% of variation in MLHF scores, identifying their substantial effect
on QOL (Rector et al., 2006).
The differences between age and gender caused minimal variation in MLHF
scores (Rector et al., 2006). Factors affecting age related differences are employment,
financial status, physical activities, and mental state. The emotional effect on QOL
negatively affected women. Women reported more dyspnea and fatigue, therefore scored
lower QOL than men (Rector et al., 2006).
Measuring QOL. The Minnesota Living with Heart Failure Questionnaire was
used to measure QOL. It is intended to measure the effects of HF and treatments on a
patient’s quality of life (Rector, 2005). Developed in 1984, the MHLFQ is the most
commonly used instrument in HF QOL research.
Reliability. Since 1984, multiple studies have tested the reliability of the
MLHFQ. The psychometric properties of the MLHFQ consistently demonstrates a
satisfactory level of reliability, > α = .80, when compared with other QOL measurement
tools (i.e., RAND-36 Short Form, Multidimensional Fatigue Inventory, and Hospital
Anxiety and Depression Scale) (Middel et al., 2001). The MLHFQ’s ability to detect a
change over time within one group was demonstrated to have a moderate effect size d =
0.65, r = 0.67. The most recent study using the MLHFQ was the Valsartan Heart Failure
Trial which resulted in a high internal consistency, α = 0.86 (Rector, 2005). High
reliability was also induced in other studies: “Evaluation by Patients with Heart Failure of
the Effects of Enalapril Compared with Hydralazine Plus Isosorbide Dinitrate on Quality
of Life”, n = 152, r = 0.87; “Assessment of Quality of Life as Observed from the
Baseline Data of the Studies of Left Ventricular Dysfunction Trial Quality of Life
Substudy” for the NYHA Class I group, n = 135, α = .95 and the NYHA Class II group,
n = 123, α = .94; “Discriminant Properties of Commonly Used Quality of Life Measures
in Heart Failure”, of NYHA Class I - IV patients, n = 211, α = .95; and “Psychosocial
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Variables and Hospitalizations in Persons with Chronic Heart Failure” of NYHA Class I IV patients, n = 62, α = .92. The MLHFQ consistently shows a high reliability, α > .8
(Rector, 2005).
Validity. MLHFQ scores significantly varies between NYHA Class groups in
multiple studies, p < .0001 (Rector, 2005). A psychometric study of the MLHFQ
demonstrated a discriminative ability of, z = -3.8, p = .0003, d = 1.25, between the
NYHA Class mean overall scores for the NYHA Class I, 11.7 (16.5), n = 15, and NYHA
Class II/III, 33.9 (18.1), n = 38, (Middel et al., 2001). Rector (2005) verified the
MLHFQ’s correlation with other HF measurement tools: Chronic Heart Failure score, r =
.81; Functional Status Scale r = .75; Dyspnea scale, r = .52; Six-minute Walk Test r =
.39; and Ejection Fraction, r = .03 (Rector, 2005). The MLHFQ’s test-retest ability was
tested over a three month period showing a satisfactory correlation between the scores,
but the change was not significant, r = .73, z = -1.28, p = .20 (Middel et al., 2001). The
mean pretest score was, 29.79 (18.65) and the three months mean posttest score, 26
(20.34) (Middel et al., 2001).
Scoring. The MLHFQ score range from 0 to 105, the higher the score the lower
the QOL. According to Rector (2005) there is not a definitive cutoff value to determine
improvement or deterioration in QOL when scoring the MLHFQ. The author states that
the total score represents the best measure of how HF has affected a patient’s QOL, even
if all of their individual question responses are not consistent.
Multiple randomized controlled studies have shown the MLHFQ’s ability to
detect differences between interventions (Rector, 2005). Studies that used the MLHFQ
vary in their interpretation of a clinically meaningful worsening or improvement of
scores. Small groups of patients reporting they felt markedly (i.e., improvement of score
by 21 points), moderately (i.e., improvement of score by 14 points), or mildly (i.e.,
improvement of score by 12 points) improved had significant changes in their scores.
Patients that reported they were feeling slightly worse had an average worsening of their
score by 3 points. The differences between NYHA classes equated to a 16-point
difference on the MLHFQ (Rector, 2005).
Summary. There are multiple factors that affect the QOL of patients with HF
including symptom distress, comorbidities, functional capacity, psychological factors,
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NYHA Classification, age, and self-care performance. HF symptoms may lead to
functional limitations which negative affects QOL. Some symptoms that may limit ADL
functioning and negatively impact QOL include drowsiness, fatigue, and shortness of
breath. In addition to these physical symptoms, psychological factors are also a strong
influence. Studies have shown that successful self-care performance may diminish
symptom distress, improve functional capacity, and therefore enhance QOL. The
MLHFQ have shown to be reliable and valid in measuring the QOL of patients with HF.
Summary
Heart failure is a growing and costly health problem in the United States.
Advancements in medical science have not prevented frequent exacerbations or hospital
readmissions. The reason for this may be a deficiency in heart failure self-care strategies
by patients. Literature review has shown that self-care is the most important aspect of
disease management. Self-care is characterized by self-care maintenance and
management activities. Self-care maintenance includes treatment adherence and
symptom monitoring. Health diaries may be useful in recording and improving self-care
maintenance. Self-care management involves the process of recognizing symptoms,
taking appropriate action, and re-evaluating the effectiveness. Adequate self-care
performance may be key to preventing frequent exacerbations and hospital readmissions.
Heart failure diagnosis is attributed to a diminished quality of life for patients.
HF symptoms impair patients’ abilities to function with ADL. Impaired functional
capacity is directly related to QOL. Studies have shown that successful self-care
performance may diminish symptom distress, improve functional capacity, and therefore
enhance QOL. The study hypothesizes that the use of a heart failure diary will improve
self-care and quality of life for patients with heart failure.
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Chapter Three: Methodology
The purpose of this one group pretest-posttest study design was to determine the
effect of using a health diary on self-care and QOL for patients with HF. The study used
a non-randomized convenience sampling of patients receiving treatment at the outpatient
HF Clinic. Non-randomization was achieved by assigning a code number by order of
participation. The intervention included individualized education, provision of a HF
diary, and weekly follow-up. The effects of the intervention were determined by
comparing the participants’ pre/post intervention responses to questionnaires, which
measured self-care and QOL of patients with HF. The literature review suggests that
self-care maintenance activities (i.e., symptom monitoring and treatment adherence)
improved overall self-care performance and QOL for patients with HF. The
methodology chapter presents the study’s recruitment process, sample, setting, data
collection, instruments, statistical analysis, and protection of human subjects.
Recruitment Process
The target population included individuals participating at an outpatient HF Clinic
in northeast Florida. Upon the University of North Florida Institutional Review Board
(IRB) (see Appendix A) and hospital Institutional Review Committee (IRC) (see
Appendix B) approval, study participants were recruited over a period of two weeks at
the HF Clinic. A verbal group presentation was made and a letter (see Appendix C)
describing the study and a copy of the Informed Consent (see appendix D) was provided
for those interested. A total of 31 patients were available for the presentation, 17
volunteers signed the consent, and 14 individuals actually participated in the study.
Population
The study consisted of a one group non-randomized convenience sample, totaling
14 volunteers. The inclusion criteria were diagnosis of HF, any gender, over the age of
21 years, and any ethnicity. The ability to read, write, and speak English was also an
inclusion criteria. A self-confirmation of HF diagnosis, length of diagnosis, length of
participation at the HF Clinic, age, gender, and ethnicity was established on the
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demographic form (see Appendix E). Individuals legally blind, deaf, cognitively disabled
(e.g., confusion, dementia, or Alzheimer’s Disease) or physical disabilities (e.g., inability
to write and stand up independently on a scale) were not included in this study. HF
Clinic participants were mostly geriatric patients with multiple comorbidities. According
to all the participants, their doctors referred them to the clinic due to frequent HF
exacerbation hospitalizations.
Setting
The setting was an outpatient HF Clinic in northeast FL. The clinic consists of
eight recliners with individual cardiac monitors, television with headset, and curtain for
privacy. Some patients receive weekly or biweekly inotrope infusion (i.e., cobutamine,
milrinone), for an average duration of six hours. Other patients receive an intravenous
bolus of a diuretic (e.g., furosemide or bumatadine), for an average duration of 30
minutes. The clinic is staffed with three registered nurses and a nursing assistant.
Tools
Self-Care of Heart Failure Index. The Self Care of Heart Failure Index
(SCHFI) (see Appendix F) was used in this study to measure self-care adequacy. It
consists of three separate sections of self-care maintenance, self-care management, and
self-care confidence (Riegel, Lee, Dickson, & Carlson, 2009). This instrument uses a
Likert scale for self-report of HF self-care achievement (Riegel et al., 2004). The
numerical values range from 1-4, depending on the frequency of self-care maintenance
activities. For the purpose of the study’s focus on self-care maintenance, only Section A
of the SCHFI questionnaire was used. The SCHFI was published in the Journal of
Cardiovascular Nursing in 2009, placed in the public domain by the authors, and
therefore permission for use was not required (Riegel et al., 2009). The self-care
maintenance section of the SCHFI has a low coefficient alpha, α = .597. The validity of
the SCHFI was assessed qualitatively and quantitatively through several studies discussed
in the literature review section. Each patients SCHFI scores were measured pre and post
intervention. The effect of the intervention on self-care was determined by calculating
the difference between the pre and post intervention SCHFI scores.
Minnesota Living with Heart Failure Questionnaire. The Minnesota Living
with Heart Failure Questionnaire (MLHFQ) was used in this study to measure QOL (see
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Appendix G). The questionnaire consists of 21 items in a 6-point Likert format, ranging
from 0-5. It requires patients to indicate on a 6-point scale (i.e., 0: no, 1: very little, and
5: very much) how each question prevents them from living as they wish, over the past
four weeks (Rector, 2005). The questions reflect the four factors affecting QOL for
patients with HF including physical, emotional, social, and mental states (Rector, 2005).
Permission for use was granted on May 31, 2009 (see Appendix H1-H4). The MLHFQ
consistently demonstrates a satisfactory level of reliability, > α = .80. Validity has been
determined in several studies, as discussed in the literature review section. Each patients
MLHFQ scores were measured pre and post intervention. The effect of the intervention
on QOL was determined by calculating the difference between the pre and post
intervention MLHFQ scores.
Heart Failure Diary. This investigator developed the Heart Failure Diary (see
Appendix I1-I3) that was used in this study. The ledger, journal, daily, and retrospective
diary designs were all incorporated into the HF diary. The diary was formatted for
patients to record their daily weight, weight gain/loss, fluid intake, salt intake, shortness
of breath, swelling, and medication adherence. These are common self-care instructions
given to patients with HF. The diary was a folder containing four weeks’ worth of
recording, each week separated by a tab and a cover page with the PI’s contact
information. Each section includes an area for totaling weekly weight gain/loss and note
taking. Individuals were encouraged to record any questions or concerns they may have
in the diary, so that it may be discussed during their follow-up with the PI. Participants
were instructed to record in the HF diary over a four-week period. They were instructed
to record their weight in the morning and other entries at the end of the day. For visual
assistance, each day was a different color. A visual analogue scale (VAS) and visual
interval scale (VIS) was used for ease of recording and to give patients the freedom to
express their responses without assumed influence from the investigator or the design of
the instrument.
Visual analogue scales have been used in many studies, appearing in the majority
of pain and mood literature, since the 1960s (Wewers & Lowe, 1990). Patients are
instructed to record their daily weight in pounds. A daily weight gain was logged by
circling a positive value (i.e., +1 to +5) on the HF diary VIS. A daily weight loss was
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logged by circling a negative value (i.e., -1 to -5) on the HF diary VIS. Patients circled 0
if there was no change in their weight. A VAS format was used to measure fluid intake,
salt intake, shortness of breath, and medication adherence. Patients were required to
record their responses between two extremes. For fluid intake, the range was between
‘no fluid’ to ‘lots of fluid’. For salt intake, the range was between ‘no salt’ to lots of
salt’. For shortness of breath, the range was ‘no shortness of breath’ to very ‘short of
breath’. For swelling, the range was ‘no swelling’ to lots of swelling’. For taking
medications, the range was ‘no meds’ to ‘all meds’. Specific and individual diary entries
will not be used for statistical analysis. The effects of keeping and logging in the HF
diary entry will be determined by summarizing the difference between the pretest-posttest
SCHFI and MLHFQ scores.
Data Collection
The primary investigator (PI) conducted all the steps of the study procedures.
After the recruitment process, those willing to volunteer in the study contacted the PI. A
UNF IRB and hospital IRC Informed Consent (see Appendix B) were completed prior to
the start of the intervention. The study procedures were categorized into weekly
interventions. For convenience, the majority of the interventions were performed at the
HF Clinic during the patients’ scheduled treatment. For those not present, follow-up was
made via telephone. The total duration of the study was between five and six weeks,
depending on each patient’s weekly or biweekly schedule at the clinic.
Week One. It was necessary that the first week of the intervention be conducted
at the HF Clinic. For privacy, the individual curtains were closed unless requested
otherwise. Each participant completed a demographic form, Self Care of Heart Failure
Index (SCHFI) questionnaire (see Appendix D), and a Minnesota Living with Heart
Failure Questionnaire (MLHFQ) (see Appendix E). After the completion of the
demographic form and questionnaires, participants were given individualized patient
education using “Heart Failure: A Patient Guidebook” (see Appendix K) (Baptist
Medical Center, n.d.). Each participant was provided and instructed on the Heart Failure
Diary (see appendix I1-I3) developed by the PI.
Week Two. Some participants were not scheduled for treatment at the clinic
during week one of the study intervention. These participants completed the
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demographic form, answered questionnaires, received patient education, and instructed
on the use of the Heart Failure Diary during week two. For the remaining participants
that were present on week one, they received follow-up either at the clinic or by
telephone. Follow-up consisted of assisting participants to calculate their total weekly
weight loss/gain. The PI also discussed any questions or concerns with each patient.
Week Three and Four. During week three to week four, the PI followed-up with
participants at the HF Clinic during their scheduled treatment time. However, those that
were not available at the clinic were followed-up through a telephone call.
Week Five and Six. The study intervention concluded during these two weeks.
For participants available on week one of the study intervention, week five was their final
week of participation. First, the PI assisted patients to calculate their weekly weight
gain/loss and discussed any questions. Second, each individual’s Heart Failure Diary was
collected. A copy of the diary was provided upon request. Third, each participant
completed the MLHFQ and SCHFI questionnaires. After completion of the
questionnaires, the PI reviewed with each participant their before/after scores and
discussed any questions. Fourth, participants voluntarily completed an Evaluation Form
(see Appendix J). The PI then provided participants with a letter thanking them for their
participation (see Appendix K). For participants not present at the clinic during week
five, their participation concluded on week six.
Statistical Analysis
Analysis of the data was conducted using the SPSS v18 software. The
significance, p, of the difference between the questionnaires’ (i.e., SCHFI and MLHFQ)
total scores and individual question responses were analyzed using the paired t-test. The
correlation between demographic data and total scores were determined by estimating the
Pearson product-moment correlation coefficient, r.
Protection of Human Subjects
The UNF IRB and hospital IRC determined the protection of human subjects by
approving the study protocol in its entirety (see Appendix A and B). Access to medical
records (e.g., patient charts) was not necessary. A portable locking file tote was used for
transportation and storage, prior to the scanning of documents. After scanning, all forms
were shredded. All documents were stored into a secure password protected UNF server
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in separate folders. Each folder was also protected with individual passwords. Only the
PI had access to the UNF server.
Patient identifiers (i.e. name, phone number, and participant number) were
included on the informed consent and master list (see Appendix L). Participants provided
their phone number on the Informed Consent, to be used by the PI for follow-up. The
information on the Master List included participant number, name, and phone number.
These documents were separated from the patient response forms at all times. Each
patient was assigned a non-randomized, by order of participation, participant number.
The participant numbers, placed in the document header, corresponded to participant
response forms (i.e., Demographic Form, SCHFI, MLHFQ, and HF diary). The
evaluation form did not include identifiers or participant numbers, it was also scanned
into the server and then shredded. After completion of data collection and analysis, all
documents stored in the UNF server were deleted forever.
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Chapter Four: Results
The purpose of the study was to determine the effects of using a HF diary on selfcare and QOL. This investigator hypothesized an improvement in self-care and QOL of
patients with HF after the use of a diary. The intervention included individualized HF
education, provision of a HF diary, and weekly follow-up. The length of the intervention
was a total of five weeks for each participant. The intervention effects were calculated by
comparing pretest-posttest SCHFI and MLHFQ scores with paired sample T-testing. A
total of 14 patients participated in the study.
Demographic Data
The study sample consisted of 14 participants. The average age of study
participants ranged from 39 to 72 years, with a mean of 62.357 (9.620) years. The
average length of diagnosis ranged from six months to three years, with mean of 5.25
(4.99) years. The length of HF Clinic participation ranged from three months to three
years, with a mean of 2.20 (3.422) years. There were an equal number of males/females
(i.e., 7) and Caucasians/African Americans (i.e., 7). The Caucasian group consisted of
four women and three men. The African American group consisted of three women and
four men.
Self-Care of Heart Failure Index
Total Scores. The total score for the self-care maintenance (i.e., Section A)
portion of the SCHFI was recalculated for a 100-point scale by the formula, (sum of
Section A items – 10) 3.333, as recommended by the developers Riegel et al. (2009).
The minimum score is 10 and the maximum 100, with >70 considered adequate self-care
maintenance. The effects of the intervention were calculated by subtracting the posttest
from the pretest scores. An improvement in self-care maintenance is represented by a
positive value of the difference (e.g., 5). A decline in self-care maintenance is
represented by a negative value of the difference (e.g., -5).
The participants, n = 14, completed the SCHFI questionnaire prior to and after the
intervention. There were minimal differences between the pretest-posttest scores for
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most of the participants (see Figure 4). The mean pretest score was 64.459 (9.291), SE =
2.483. The mean posttest score was 67.076 (13.565), SE = 3.625. The difference
between the mean pretest-posttest scores were, 2.616 (12.942), SE = 3.459. The
difference in pretest-posttest scores resulted in a minimal improvement of self-care
maintenance adequacy, but according to the paired sample t-test was not significant, p =
.463, t = -.756, 95% CI [-10.089, 4.856]. Additionally, the paired sample test of the
participants’ total pretest and posttest scores were not significantly correlated, r = 0.408,
p = 0.148. For example, a high or low pretest score did not determine the posttest score.
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Figure 4. Comparison of the Self-Care of Heart Failure Index total scores for each
participant, pre-intervention and post-intervention, demonstrates insignificant change.
Individual Question Analysis. The significance of the difference from pretestposttest responses, for each individual question of the SCHFI, was analyzed using paired
t-test (See Table 1). Questions 3 (i.e., avoiding sick people), 4 (i.e., doing physical
activity), 5 (i.e., keeping provider appointments), 7 (i.e., exercising for 30 minutes), and 9
(i.e., asking for low salt items) were significantly positively correlated, meaning pretest
and posttest responses were associated in such a way that low pretest scores were
associated with low posttest scores and high pretest scores associated with high posttest
scores. That is, the individual posttest responses to these questions were similar to the
pretest. There was borderline correlation between the pretest and posttest response for
question 1 (i.e., weighing yourself). The paired sample analysis did not show a
significant difference between the pretest and posttest responses, for each individual
question (see Figure 5).
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Table 1
Self-Care of Heart Failure Index Individual Question Analysis
Question

Mean

SD

SEM

r (p)

t

p

1

-.286

.726

.194

.523 (.055)

-1.472

.165

2

-.071

.730

.195

.349 (.221)

-.366

.720

3

-.286

.726

.194

.776 (.001)**

-1.472

.165

4

-.071

.730

.195

.629 (.016)*

-.366

.720

5

.000

.392

.105

.679 (.008)*

.000

1.000

6

.500

.941

.251

.452 (.105)

1.989

.068

7

-.071

.616

.165

.826 (.000)**

-.434

.671

8

-.143

1.231

.329

-.085 (.771)

-.434

.671

9

-.286

.726

.194

.750 (.002)*

-1.472

.165

10

-.071

.730

.195

.667 (.009)

-.366

.720

Note: Comparing the correlation, r (p), and the difference, p, between each individual question for all
participants (n = 14, df = 13).
*p < .05, ** p < .001.
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Figure 5. Comparison of the Self-Care of Heart Failure Index pretest and posttest mean
responses for each question, demonstrates non-significant change.

Demographic Correlations. The difference between the pretest-posttest total
mean scores was analyzed for correlation with demographic data (i.e., age, gender,
ethnicity, length of diagnosis, and length of participation at the HF Clinic). There was
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not a significant correlation with age, r = .090, p = .759; gender, r = -.080, p = .787;
length of diagnosis, r = .083, p = .777; or length of participation at the HF Clinic, r =
.326, p = .255.
There was a strong correlation between the difference in total pretest-posttest
mean score and ethnicity, r = .782, p = .001. This was further analyzed by paired sample
testing of the pretest minus posttest score differences (see Table 2). A negative value
represents improvement. A positive value represents worsening. The total scores for
Caucasian patients improved by a mean of 12.379 points and statistically significant, p =
.003. The total scores for the African American patients declined by an average of 7.142
points, but not statistically significant, p = .105.

Table 2
Self-Care of Heart Failure Index Score and Ethnicity Correlation
Ethnicity

Mean

SD

SEM

Caucasian

-12.379

6.586

2.489

African American

7.142

9.892

3.739

95% CI

t

p

-18.470, -6.288

-4.973

.003*

-2.007, 16.291

1.910

.105

Note: *p < 0.05.
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Figure 6. Comparison of the Self-Care of Heart Failure Index difference in pretestposttest mean responses for each question, demonstrates a contrast between the African
American and Caucasian ethnic groups. Further demonstrating the significant
improvement of self-care adequacy in the Caucasian compared to the African American
group.
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Minnesota Living with Heart Failure Questionnaire
Total Score. The MLHFQ scoring system is based on a 100 points scale, with a
minimum score of 0. An increase in total score represents a worsening in quality of life,
and a decrease for improvement. The intervention effect was calculated by subtracting
the posttest from the pretest score. An improved HF QOL is represented by a negative
value (e.g., -5) of the difference. A worsened HF QOL is represented by a positive value
(e.g., 5) of the difference.
Participants, n = 14, completed the MLHFQ questionnaire prior to and after the
intervention. There were minimal changes between the total pretest and posttest scores
for most of the participants (see Figure 5). The mean pretest score was 57.29 (28.253),
SE = 7.551. The mean posttest score was 51.79 (26.635), SE = 7.118. The difference
between the mean pretest-posttest scores were, -5.500 (18.851), SE = 5.038. The
difference in pretest-posttest scores resulted in a slight improvement in HF QOL, but
according to the paired sample test was not significant, p = .295, t = 1.092, 95% CI [5.384, 16.384]. Additionally, the total pretest and posttest scores were highly positively
correlated, r = 0.77, p = 0.001. Meaning, those who scored a high pretest score also
scored higher on the posttest.
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Figure 7. Comparison of the Minnesota Living with Heart Failure Questionnaire pretest
and posttest scores for each participant demonstrates improvement in QOL, but
insignificant.
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Individual Question Analysis. The significance of the difference from pretestposttest responses, for each individual question of the MLHFQ, was analyzed using
paired t-test (Figure 8 and Table 3). The pretest and posttest responses were significantly
correlated for questions 1 (i.e., causing swelling), 3 (i.e., making walking and climbing
stairs difficult), 4 (i.e., making working around the house and yard difficult), 5 (i.e.,
making going away from home difficult), 7 (i.e., making relating to or doing things with
friends/family difficult), 9 (i.e., making recreation, hobbies, and sports, difficult), 12 (i.e.,
making you short of breath), and 14 (i.e., making you stay in the hospital). Meaning,
pretest and posttest responses were associated in such a way that low pretest scores were
associated with low posttest scores and high pretest scores associated with high posttest
scores. For question 9, the paired sample analysis showed a significant pretest-posttest
difference, p = .029, and correlation, r = .573, p = .032. For question 8, it also showed a
borderline significant pretest-posttest difference, p .063, but no significant correlation.
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Figure 8. Comparison of the MLHFQ pretest and posttest mean responses for each
question, demonstrates mostly insignificant change, except for question 8 and 9 of which
could be due to chance since there were 21 tests performed at the 5% level of
significance.
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Table 3
Minnesota Living with Heart Failure Questionnaire Individual Question Analysis
Mean

SD

SE

r (p)

T

p

1

.42857

1.74154

.46545

.555 (.039)*

.921

.374

2

-.14286

1.91581

.51202

.269 (.352)

-.279

.785

3

-.14286

1.35062

.36097

.661 (.010)*

-.396

.699

4

.14286

1.35062

.36097

.686 (.007)*

.396

.699

5

-.07143

154244

.41223

.670 (.009)*

-.173

.865

6

.42857

2.47182

.66062

.094 (.750)

.649

.528

7

.14286

1.46009

.39023

.609 (.021)*

.366

.720

8

1.14286

2.10703

.56313

.480 (.083)

2.029

.063

9

1.14286

1.74784

.46713

.573 (.032)*

2.447

.029*

10

.57143

2.50275

.66889

.394 (.164)

.854

.408

11

-.21429

2.04483

.54650

.389 (.170)

-.392

.701

12

.14286

1.16732

.31198

.717 (.004)*

.458

.655

13

-.07143

1.89997

.50779

.513 (.061)

-.141

.890

14

-.14286

1.23146

.32912

.811 (.000)**

-.434

.671

15

.28571

2.61441

.69873

.166 (.570)

.409

.689

16

.57143

1.69680

.45349

.595 (.025)*

1.260

.230

17

-.14286

1.09945

.29384

.877 (.000)*

-.486

.635

18

.57143

1.60357

.42857

.671 (.009)*

1.333

.205

19

.64286

2.13423

.57049

.525 (.054)

1.127

.280

20

-.14286

1.83375

.49009

.473 (.087)

-.291

.775

21

.35714

.84190

.22501

.921 (.000)*

1.587

.136

Note: * p = < .05, ** p = < .001.
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Demographic Correlations. The change in pretest-posttest scores was not
significantly different when stratified by race, t = -0.287, p = 0.779, or gender, t = -1.294,
p = 0.220. The Caucasian group had a 7-point improvement with their HF QOL score
and the African American group had a 4-point improvement. Unlike the SCHFI, both
ethnic groups had a slight improvement with their HF QOL, but statistically nonsignificant, p = .295. Change in score did not correlate with length of diagnosis, t = 0.206, p = 0.480, or length of participation at the HF Clinic, t = 0.048, p = 0.869.
The relationship between the pretest-posttest score difference and age was
moderately positively correlated, t = 2.450, p = .031, 95% CI [.006, .102]. However, if
the youngest patient who was 39 years old were removed, the moderate positive
correlation with age would not exist.
Summary
Heart Failure Diary. Patients were told prior to volunteering, that incompletion
of the HF diary will not remove them from the study. However, all of the participants for
the most part completed their diaries and this may be due to the weekly follow-up.
Completion or incompletion of the participant’s HF diaries was not used in the data
analysis. Specific entries of the HF diary were not used in the statistical analysis. The
overall effect of the intervention was analyzed through statistical analysis of the SCHFI
and MLHFQ pre/post intervention score differences.
Self-Care of Heart Failure Index. Each participant’s total pretest and posttest
scores were mostly inadequate (i.e., < 70) (see Figure 4). For both the pretest and
posttest scores, only five participants had adequate self-care scores. The difference
between pretest-posttest scores showed a non-significant improvement in self-care
adequacy, n = 14, 2.616 (12.942), SE = 3.459, p = .463, t = -.756, 95% CI [-10.089,
4.856]. The paired sample test for the correlation between the pretest and posttest total
group scores was also non-significant, r = 0.408, p = .148, but this may be due to an
artifact of the small sample size.
Individual questions were further analyzed to assess a difference and correlation
between pretest and posttest responses. Questions 3, 4, 5, 7, and 9 were significantly
correlated, meaning pretest and posttest responses were similar. However, question 9
(i.e., asking for low salt items) is the only question with significant correlation that is also
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a HF diary entry. Question 1 (i.e., weighing yourself), which had a borderline significant
correlation with the pretest and posttest responses, is also an entry in the HF diary.
However, the difference from pretest-posttest responses for these particular questions,
were found to be non-significant. Therefore, using the HF diary did not affect these
specific self-care activities (i.e., asking for low salt items and daily weight). Although
not included as a HF diary entry, question five (i.e., keeping provider appointments) had
significant correlation between pretest and posttest responses. This corresponds with the
study by Eastwood et al. (2007) that found diary users contacted healthcare providers
more than non-users. Again, the difference with question five’s pretest-posttest response
was not significant. The HF diary entries were not included in the data analysis and
therefore these relationships were not further analyzed.
There was a strong significant difference between ethnic groups. The Caucasian
group improved their total score by an average of 12 points post-intervention. The
African American group had a decline in their total score by an average of 7 points postintervention. The average age for both ethnic groups was 62 years. There was a
difference between the mean length of HF diagnosis for the African American group,
6.071 (4.891) years, compared to the Caucasian group, 4.428 (5.341) years, however this
was statistically not significant, t = .60, p = .559. There was also a difference between
the mean length of participation at the HF Clinic for the African American group, 3.535
(4.5355) years, versus the Caucasian group, 0.857 (0.788) years, however this was also
statistically not significant, t = 1.54, p = .172. Although the difference in these means
were observed, it was not statistically significant. There are contradicting information in
the literature regarding symptom awareness and the length of diagnosis. For those who
have been diagnosed with HF longer, their symptom awareness may be strong because of
their past experience with exacerbations or they may be unmoved by slight changes in
their health status by accepting it as ‘part of life’ or ‘part of getting old’. Evidence
suggests that HF clinics improve patient outcomes through frequent monitoring and
reinforcement, however whether attendance may cause the patients’ to rely more on the
clinic than themselves is unknown. The completion/incompletion and specific entries of
the HF diary were not included in the data analysis, but would be interesting to further
analyze the difference between the ethnic groups.
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Minnesota Living with Heart Failure Questionnaire. The one-group sample’s,
n = 14, pretest total mean score, 57/105, improved by 5 points, 52/105. The difference in
the MLHFQ pretest-posttest scores demonstrates a non-significant improvement of HF
QOL, n = 14, -5.500 (18.851), SE = 5.038, p = .295. However, the relationship between
the pretest and posttest scores were highly positively correlated, r = .77, p = .001.
Meaning, those who scored high on the pretest also scored high on the posttest. The
difference in the group pretest-posttest scores did not have a significant correlation with
the demographic data (i.e., race, gender, length of diagnosis, and length of participation at
the HF Clinic). Unlike the SCHFI, both ethnic groups had an improvement with their
QOL scores, but not statistically significant, t = -.287, p = .779. The moderate positive
correlation between age and MLHFQ scores was not meaningful because when the
youngest patient (i.e., 39 years) was removed from the sample data the correlation was
nonexistent.
The MLHFQ individual question analysis showed significant pretest and posttest
response correlations between questions 1, 3, 4, 5, 7, 9, 12, 14, 16, 17, 18, and 21. The
majority of these questions can be categorized into the physical subscale of the MLHFQ
and may be related to the severity of symptoms and treatment adherence. Questions 1
(i.e., swelling) and 12 (i.e., shortness of breath) are entries in the HF diary, for symptom
monitoring. Question 16 (i.e., treatment side effects) is relatable to the medication
adherence entry on the HF diary, since side effects may cause patients to be
noncompliant with their treatments. Question 9 (i.e., making recreational pastimes,
sports, and hobbies difficult) had a significant difference in pretest-posttest response, t =
2.447, p = .029. Question 8 was borderline significant with the difference in pretestminus posttest response, t = 2.029, p = .063. However, due to the multitude of questions,
21, the significance of questions 8 and 9 may be due to chance.
Null Hypothesis Retained. Paired T-testing did not show a significant difference
between the total pretest-posttest scores and individual question responses, therefore the
null hypothesis is retained. According to this study’s non-significant difference in the
SCHFI or MLHFQ scores, the use of a diary did not improve self-care or QOL of the
patients with HF. The use of a diary did not improve the self-care or quality of life of
patients with HF. Nonparametric testing for each the individual questions, using

45
Wilcoxin signed rank test, had similar results with the Paired t-test confirming that the
null hypothesis was retained. The effect size of the SCHFI, d = .20, and the MLHFQ, d
= .29, are both small and most likely due to the small sample size.
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Chapter Five: Discussion
As stated by the ACCF/AHA, close observation and follow-up is the most
effective and unfortunately least used measure in HF treatment (AHA, 2009). In order to
decrease hospitalization admission rates and lower costs, hospitals designated specific
outpatient HF clinics to closely monitor those with frequent exacerbations. According to
Eastwood et al. (2007) diary users were more likely to attend these clinics than non-users.
Self-care is a vital aspect of HF disease management, ultimately determining a negative
or positive outcome. There is strong evidence of the correlation between self-care and
quality of life in the literature. As providers, we need to continue to develop
interventions that encourage and empower patients to take control of their disease
process. The objective of this study was to determine whether the use of a diary
improved the self-care or quality of life of patients with HF.
The concept of developing a HF diary was based on the multitude of self-care
instructions (i.e., weight monitoring, fluid restriction, low sodium diet, exercise,
medication adherence, and symptom monitoring) given to patients diagnosed with HF. It
requires a change in lifestyle that can be viewed as cumbersome and others may be
resistant to a deviation from their norm. A HF diary may be beneficial as a guide and
reminder for patients to perform daily self-care activities. The diary may also be useful
as a reference for patients and providers to monitor trends.
To determine if the HF diary is a useful tool in practice, its effects on self-care
and quality of life was determined by comparing the SCHFI and MLHFQ scores pre and
post intervention. The SCHFI self-care maintenance (i.e., Section A) was chosen because
the HF diary entries (i.e., symptom monitoring and treatment adherence) specifically
relate to the individual questions. The MLHFQ was used because of its high reliability,
adequate validity, and it is commonly used in HF related research.
The one-group pretest/posttest study design included patients with a mean age of
62 years, equal number of males/females, equal number of African Americans versus
Caucasians, average length of diagnosis was five years, and average HF Clinic
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participation was two years. Prior to the intervention, the SCHFI scores were mostly
inadequate (i.e., 70) and the MLHFQ averaged in the middle of the 100-point scale. The
SCHFI pre-post intervention score differences resulted in a non-significant improvement
of self-care maintenance n = 14, 2.616 (12.942), SE = 3.459, p = .463. The MLHFQ prepost intervention score differences resulted in a non-significant improvement of QOL, n
= 14, -5.500 (18.851), SE = 5.038, p = .295. In regard to demographics, there was a
strong significant correlation between the difference in total pretest-posttest scores and
ethnicity, r = .782, p = .001. The Caucasian group had a significant improvement of selfcare maintenance adequacy, p = .003. The African American group had a non-significant
decline of self-care adequacy, p = .105. The QOL measure did not show a significant
difference with regard to ethnicity.

In conclusion, the use of a diary did not improve the

self-care or quality of life of these patients with HF.
Limitations
Significant differences may be observed with a larger sample, such as a change in
scores and demographic correlations. The demographic data was limited and should have
included other predictors of self-care (i.e., comorbidities, NYHA Class, and educational
level). This data may also be used as inclusion and/or exclusion criteria. Determining
NYHA Class and comorbidities would have required access to participants’ medical
records. A greater duration of the study intervention may have had greater impact and
significant change of scores.
The SCHFI self-care maintenance subscale has a low coefficient alpha and the
reverse scoring for question 8 (i.e., forget to take one of your medications) complicates
the investigator’s calculations and participants’ responses. There is random error present
in both questionnaires (i.e., SCHIF and MLHFQ), which is present in all instruments.
Analysis of the specific HF diary entries (i.e., completion/incompletion, weight changes,
symptom severity, monitoring adequacy, and treatment adherence) may have provided
greater information on their effects on self-care and QOL.
Exercise should have been added as a diary entry, as it is strongly encouraged for
patients with HF. The initial plan was to include only symptom monitoring activities in
the diary. When the decision was suggestion was made to include medication adherence,
the investigator mistakenly forgot to include exercise. This investigator recognizes the
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major flaw of not including exercise as a diary entry, which is encouraged and
emphasized in HF management.
Randomization, with a control and experimental group, would further prevent bias
and determine a significant difference between diary users and nonusers. The
investigator’s past experience in caring for these patients in the HF Clinic was an existing
bias. During the whole duration of this study, the investigator’s role was only of a
student researcher. The investigator’s past history with study participants may have
influenced their decision to participate, responses to the questionnaire, and completion of
the HF diary.
Implications for Further Study
The HF diary entries included symptom monitoring (i.e., weight changes,
shortness of breath, and swelling) and treatment adherence (i.e., fluid intake, salt intake,
and medication adherence). Further data analysis may focus on the HF diary entries’
(i.e., individual entries and level of completion) effect on self-care adequacy and QOL.
Predictors of self-care adequacy and QOL (i.e., comorbidities, education level, and
NYHA classification, functional capacity, emotional/mental state, socioeconomic, and
social support) may provide additional information. Future studies can investigate
healthcare disparities, including the ethnic variance in self-care adequacy. Beyond selfcare maintenance, the benefits of the HF diary may be assessed in regard to self-care
management and confidence. The VAS format may continue to be used in the diary
design, because the point of entries can be quantified with a measurement ruler. Doing
so, may further determine each participants’ level of symptom severity and treatment
adherence. If proven to be beneficial, the diary may be useful to reinforce HF patient
education and management.
Implications for Nursing Practice
Nurse practitioners are employed in a variety of areas in the healthcare industry.
Primary care nurse practitioners are involved in the care and management of patients with
HF. In these settings, there may be minimal time allotted for education and
reinforcement. Tools, such as a HF Diary, may be beneficial in expediting education and
empowering patients. A diary may also serve to assess adherence, reinforce self-care,
evaluate adequacy, monitor trends to prevent exacerbations, and assist in improving
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QOL. Nurse practitioners must continue researching ways to incorporate education and
health promotion into their daily practice that will attract interest and simplify adherence.
Summary
As healthcare costs continue to rise, there needs to be greater focus on preventing
illness and its complications. It is more costly to develop new drugs and technology than
allowing time to provide appropriate education and reinforcement. Healthcare providers
must continue to be creative in encouraging patients to feel empowered in taking control
of their health.
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Appendix B
Hospital IRC Approval

Institutional Review Committee
September 13, 2010
Claudette Walker, BSN, RN

RE: .#10-44, University of North Florida, "Effects of the Use of a Heart Failure Diary on
Self-Care and Quality of Life".
-Protocol Submission Checklist; summary letter; UNF IRB Approval dated 16 August
2010; Protocol, revision July 2009; Consent document, version date 16 August 2010;
Financial Disclosure forms; Heart Failure Diary.

Dear Ms. Walker:
The Institutional Review Committee (IRC) of Baptist Medical Center (BMC) met on
September 9, 2010, and the aforementioned new protocol was reviewed and approved via
Expedited Review for a period of one year.
The anniversary date for this study is September 8, 2011. At that time, please submit a
report of your experiences with this protocol.
Should you have any questions, please contact the IRC office. The BMC IRC meets the
requirements in 21 CFR 56 (Rev.), 45 CFR 46 (Rev.) and ICH (E6) GCP guidelines.
Good luck with this endeavor.
Signature Deleted

Chairman Institutional Review Committee
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Appendix C
Introduction Letter
Date: July 1, 2010
Dear HF Clinic Participant:
My name is Claudette Walker. I am a Baptist Medical Center RN and a graduate student at the University
of North Florida School of Nursing. First, I would like to ‘thank you’ for taking time during your treatment
session at the HF Clinic to listen to the research study presentation. I’d like to provide you with the
information below in considering participation in the research study.
The title of my research is: Effects of the use of a Heart Failure Diary on Self-Care and Quality of Life.
The purpose of my study is to examine the effect of a Heart Failure Diary on Self-Care and Quality of Life
for patients with Heart Failure. Participation in the study is voluntary and involves completion of an
informed consent, demographic form, questionnaires, and a HF Diary. Information required on the
demographic form includes: diagnosis of Heart Failure (yes/no), length of HF diagnosis (years/months),
length of participation at the HF Clinic (years/months), age, gender, and ethnicity. There are two
questionnaires that will be completed in the beginning and the end of the study. The first questionnaire is
called the Self-Care of Heart Failure Index and measures your Heart Failure self-care activities. The
second questionnaire is called the Minnesota Living with Heart Failure questionnaire and measures how
Heart Failure has affected your quality of life. You will be given individualized education using the Baptist
Medical Center Heart Failure: A Patient Guide book. You will also be provided a Heart Failure Diary to
record your daily weight, weight gain/loss, fluid intake, salt intake, shortness of breath, swelling, and
medications taken. I will instruct you on how to use the Heart Failure Diary. Please try your best to fill out
the diary every day for the duration of 4 weeks.
The total duration for participating in the study is 5-6 weeks, each session will take between 15-60 minutes
of your time. I will follow-up with you on a weekly basis, during your scheduled treatment day at the HF
Clinic or by telephone. You will be provided with my contact information in case you have any questions
or concerns throughout the study process.
There are no anticipated or potential social, legal, employment, or financial risk for you to participate in the
study. The foreseeable risks include feeling ‘tested’ when completing questionnaires and distracted
because of the group setting. There is also a risk that you may feel pressured to participate by thinking that
your refusal will affect the level of care received or opinions held by the HF Clinic staff. Remember that
participation is voluntary and will not change any treatment or care that is being provided by the HF Clinic
staff. You may feel pressured to fully complete all sections of the HF Diary, however not being able to
fully complete the diary will not have any negative consequences. The cost of the study is your time,
however the majority will be done at the HF Clinic during your scheduled treatment day or by telephone.
Please contact me of any further questions you may have regarding the study. I hope you will consider
volunteering and participate in the research study.
Sincerely,
Claudette Walker RN BSN
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Appendix D1
Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires:09/09/2011

INFORMED CONSENT TO PARTICIPATE IN A RESEARCH STUDY
This form explains the research. This form also lists the information about you that will
be obtained during the study, how it will be used, and with whom it will be shared. You
should understand the study well before you agree to participate. The people in charge of
the study will answer your questions about it at any time. We encourage you to ask
questions and take the opportunity to discuss the study with anybody you think can help
you make this decision.
1. WHAT IS THE TITLE OF THE STUDY? Effects of the use of a heart failure diary
on self-care and quality of life
2. WHO IS IN CHARGE OF THE STUDY AT BAPTIST MEDICAL CENTER?
Principal Investigator: Claudette Walker RN BSN
Address: Jacksonville Beach, FL 32250
Phone #: H (904) 241-0939 C (904) 403-7231
Co-Investigators: Katherine Robinson, RN, PhD
University of North Florida
(904) 620-1459
Research Coordinator: Claudette Walker RN BSN
Contact Information:
Phone: (904) 403-7231
Email: claudettewalker@gmail.com
3.WHO SHOULD RESEARCH PARTICIPANTS CONTACT ABOUT THEIR
RIGHTS?
Chairman, Baptist Medical Center Institutional Review Committee at (904) 202-2127.
Dr. Katherine Kasten, Chairperson of University of North Florida IRB (904) 620-2498.
4. WHAT IS THE PURPOSE OF THE STUDY? The purpose of this study is to
determine the effects of using a heart failure diary on self-care and quality of life.
5. WHO IS SPONSORING OR PAYING FOR THE STUDY? The University of North
Florida is the primary sponsor

Version date 8/16/2010Page

1 of 9
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

6. WILL THE INVESTIGATORS MAKE MONEY FROM THIS STUDY? NO
7. WHO CAN BE IN THE STUDY? Patients participating in the HF Clinic at Baptist
Medical Center Downtown, who are over the age of 21 years, speak English as primary
language, and are able to read and write in English.
8. HOW MANY OTHER PEOPLE WILL BE IN THE STUDY? 20
9. HOW LONG WILL PARTICIPATION IN THE STUDY LAST? 5-6 weeks depending
on your HF Clinic treatment schedule. The length of time for each session depends on the
week: Week 1 (30min-1hour), Week 2 (15- 30min), Week 3 (15-30min), Week 4 (1530min), Week 5/Week 6 (30min- 1hour).
10. WHAT ARE THE RESEARCH PROCEDURES?
During this study: (curtains will be closed during activities for privacy)
1) If you volunteer to participate, you will sign an informed consent.
2) Week 1:
a) You will complete 2 questionnaires about:
i) Heart Failure Self-care
ii) Heart Failure Quality of Life
b) b.You will complete a demographic form, information required includes:
i) Have you been diagnosed with Heart Failure (yes/no)
ii) How long have you had Heart Failure (years/months)
iii) How long have you been participating at the Heart Failure Clinic?
(years/months)
iv) Age (years)
v) Gender (male/female)
vi) Ethnicity (Caucasian, African American, Hispanic, Asian, Other)
c) You will receive one-on-one education about Heart Failure: using the Baptist
Medical Center Heart Failure: A Patient Guide book
d) You will be provided and instructed on how to use the Heart Failure Diary
3) Week 2:
a) a.We will review the diary together at the HF Clinic or by phone
b) b. We will discuss any questions/concerns you may have

Version date 8/16/2010

Page 2 of 9

55
Appendix D3
Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

4) Week 3:
a) We will review the diary together at the HF Clinic or by phone
b) We will discuss any questions/concerns you may have
5) Week 4:
a) We will review the diary together at the HF Clinic or by phone
b) We will discuss any questions/concerns you may have
6) Week 5:
a) We will review the diary together at the HF Clinic
b) We will discuss any questions/concerns you may have
c) You will complete the 2 questionnaires again
i) Heart Failure Self-care
ii) Heart Failure Quality of Life
iii) We will review your before and after questionnaire results
d) You will complete an evaluation form
e) The diaries will be collected. If you want, you can be given a copy.
7) Week 6: *if you’re not scheduled for a HF Clinic treatment for Week 5
a) We will review the diary together at the HF Clinic
b) We will discuss any questions/concerns you may have
c) You will complete the 2 questionnaires again
i) Heart Failure Self-care
ii) Heart Failure Quality of Life
iii) We will review your before and after questionnaire results
d) You will complete an evaluation form
e) The diaries will be collected. If you want, you can be given a copy.
11. WHAT ARE POSSIBLE RISKS OF BEING IN THIS STUDY? There are no
anticipated or potential social, legal, employment, or financial risks for those
participating in the study. A psychological stress of feeling insecure about being 'tested'
or feeling distracted, may be experienced during the completion of questionnaires even
with the individual curtains closed for privacy. The questionnaires are not a 'test' but an
evaluation of where self-care improvement may be useful. The provided individualized
education, completion of questionnaires, and completion of diary may be viewed as time
consuming. However, the majority of the intervention will be carried out during your
scheduled treatment day at the HF Clinic for convenience, or by telephone. You may feel
pressured to fully complete all sections of the HF Diary. Not being able to complete the
diary will not have any consequences.

Version date 8/16/2010

Page 3 of 9

56
Appendix D4
Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

12.WHAT ARE POSSIBLE BENEFITS OF BEING IN THIS STUDY? You may benefit
by learning more about Heart Failure, improving your self- care skills and quality of life.
13. WHAT HAPPENS IF A PROBLEM OR INJURY RESULTS FROM THE
RESEARCH PROCEDURES? There are no anticipated problems from participating in
this study. If you feel there may be a problem or experience injury related to the study,
contact me and at that time you will be removed from the study.
14. IS BEING IN THE STUDY VOLUNTARY? Yes and you may request to be
removed from the study at any point.
15. WHAT ARE OTHER CHOICES BESIDES BEING IN THE STUDY? You may
choose to not participate in the study.
16. CAN THE RESEARCHERS REMOVE SOMEONE FROM THE STUDY?
Yes. If for any reason the researcher or IRB/IRC administrators feel you are at risk, they
may choose to stop you from participating in the study.
17. WHAT ARE THE COSTS OF BEING IN THIS STUDY? No financial costs, except
for your time spent participating in the study.
18. WILL PEOPLE BE PAID FOR BEING IN THIS STUDY? No
Neither I, University of North Florida, or Baptist Medical Center will profit from this
study. There are no financial ties or interactions with University of North Florida that
would influence the conduct of this study or the reporting of the results.
19.WILL PEOPLE IN THE STUDY BE TOLD OF ANY NEW INFORMATION THAT
MIGHT AFFECT THEIR WILLINGNESS TO STAY IN THE STUDY? If any new
information were to arise (this is not expected), you would be told.
20. WHAT INFORMATION ABOUT ME WILL BE USED OR DISCLOSED?
Your medical records will not be accessed during the study.

Version date 8/16/2010
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

The information about you that will be used for the study is:

If you have been diagnosed with Heart Failure

How long you’ve had Heart Failure

How long you’ve been participating at the HF Clinic

Age

Gender (male/female)

Ethnicity (Caucasian, African American, Hispanic, Asia, Other)

Phone Number (this is only used for weekly follow-up)
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

Your personal information including name, address, medical record number, social
security number, and detailed medical history (other than a self reported diagnosis of HF)
will not be needed for study participation. You will be assigned a code number which
will be recorded on each form completed. There will be a Master List of all participants
which will include the participant code number, the participant’s name, and telephone
number. Upon completion of informed consents, demographic data, SCHFI
questionnaire, MLHF questionnaire, evaluation forms, and Master List will be
temporarily stored in a portable locking file tote and then scanned into a password
protected secure UNF server to ensure maximm participant confidentiality. The PI will
complete the Master List on a password protected Laptop, email to a password protected
UNF email address for backup, and store
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

in a UNF secure server separate from participant responses. The Master List will be
securely stored in a separate location from participant responses at all times on UNF's
secure server. The only person who will have access to the Master List is Claudette
Walker, the PI. The only identifiers on the HF diary are participant numbers. At the
conclusion of the study, HF diary entries will also be stored in the UNF secure server.
All scanned documents will be shredded.

The results of this study may eventually be presented at meetings or in print. However,
your identity will not be disclosed in those presentations. The results of this project will
be shared with other researchers and administrators. Information may be exchanged
between investigators, but patient confidentiality will be maintained.

All information will be kept confidential. Your identity will be protected as much . as the
law permits. The Sponsor will receive information from this study. Your research
records and this signed consent form can be inspected by:

Study Management Program or representative
The U.S. Department of Health and Human Services
Baptist Medical Center Institutional Review Committee
Food and Drug Administration (FDA)

The privacy of your information cannot be guaranteed after it is disclosed, but all
attempts to maintain your anonymity will be provided.
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

21. SIGNATURES
I am making a decision whether or not to participate in the above study. I have read, or
had read to me in a language that I understand, all of the above. I have asked questions
and received answers about things I did not understand. I willingly give my consent for
my participation in this study.
My signature indicates that I give researchers permission to disclose (release) information
that identifies me, and health information about me, for this research study. I understand
that:
I can cancel this authorization/consent. The use and/or disclosure (release) of
information will stop after the cancellation is received. Information that is used or
disclosed before a cancellation may still be used.
My information may be disclosed again by the person or entity who receives it. It his
happens, Federal or State Law may not protect my information.
I have the right to refuse to sign this authorization.
If I refuse to sign this authorization, I will not be allowed to be in this research
study.
I have the right, in general, to ask the study coordinator to tell me who has
received by PHI (Protected Health Information). However, the list would not
include information that was released for research studies with signed consents.
I will receive a signed and dated copy of this authorization.
By signing this informed consent document, I am not waiving any of my legal
rights.
I consent and authorize Claudette Walker RN BSN to perform upon
__________________________ (Name of Participant) the research described above.

____________________________ ___________________________
Name of Participant (Print)
Signature of Participant
(18 years of age or older)
Participant Phone# _____________________
Claudette Walker RN BSN____________________________
Name of Person Administering
Signature of Person
Consent
Administering Consent
Version date 8/16/2010

____________
Date

___________
Date
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Informed Consent
IRC Approved: 09/10/2010
Last Approval: 09/10/2010
Expires: 09/09/2011

I, the undersigned, certify that to the best of my knowledge, the subject/legal
representative signing this consent had the study fully and carefully explained. He/she
clearly understands the nature, risks and benefits of participation in this process.

_______________________________
Signature of Investigator/Designee
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Date
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Appendix E
Demographic Form

-1-

DEMOGRAPHIC FORM

Have you been diagnosed
with Heart Failure?
How long have you had
Heart Failure?
How long have you been
participating at the Heart
Failure Clinic?
Age
Gender
Ethnicity

YES

NO

(years/months)

(years/months)
(years)
MALE
FEMALE
Caucasian
African American
Hispanic
Asian
Other
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Self-Care of Heart Failure Index

-1SELF-CARE OF HEART FAILURE INDEX
All answers are confidential.

Think about how you have been feeling in the last month or since we last spoke as
you complete these items.
SECTION A:
Listed below are common instructions given to persons with heart failure. How routinely
do you do the following?
Never or

Sometimes

Frequently

rarely

Always
or daily

1.

Weigh yourself?

1

2

3

4

2.

Check your ankles for swelling?

1

2

3

4

3.

Try to avoid getting sick (e.g., flu shot,
avoid ill people)?

1

2

3

4

4.

Do some physical activity?

1

2

3

4

5.

Keep doctor or nurse appointments?

1

2

3

4

6.

Eat a low salt diet?

1

2

3

4

7.

Exercise for 30 minutes?

1

2

3

4

8.

Forget to take one of your medicines?

1

2

3

4

9.

Ask for low salt items when eating out or
visiting others?

1

2

3

4

10. Use a system (pill box, reminders) to help
you remember your medicines?

1

2

3

4
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Minnesota Living with Heart Failure Questionnaire

-1-

MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE
!

The following questions ask how much your heart failure (heart condition) affected your
life during the past month (4 weeks). After each question, circle the 0, 1, 2, 3, 4 or 5 to
show how much your life was affected. If a question does not apply to you, circle the 0
after that question.
Did your heart failure prevent
you from living as you wanted during
the past month (4 weeks) by -

No

Very
Little

Very
Much

1. causing swelling in your ankles or legs?
0
1
2
3
4
5
2. making you sit or lie down to rest during
the day?
0
1
2
3
4
5
3. making your walking about or climbing
stairs difficult?
0
1
2
3
4
5
4. making your working around the house
or yard difficult?
0
1
2
3
4
5
5. making your going places away from
home difficult?
0
1
2
3
4
5
6. making your sleeping well at night
difficult?
0
1
2
3
4
5
7. making your relating to or doing things
with your friends or family difficult?
0
1
2
3
4
5
8. making your working to earn a living
difficult?
0
1
2
3
4
5
9. making your recreational pastimes, sports
or hobbies difficult?
0
1
2
3
4
5
10. making your sexual activities difficult?
0
1
2
3
4
5
11. making you eat less of the foods you
like?
0
1
2
3
4
5
12. making you short of breath?
0
1
2
3
4
5
13. making you tired, fatigued, or low on
energy?
0
1
2
3
4
5
14. making you stay in a hospital?
0
1
2
3
4
5
15. costing you money for medical care?
0
1
2
3
4
5
16. giving you side effects from treatments?
0
1
2
3
4
5
17. making you feel you are a burden to your
family or friends?
0
1
2
3
4
5
18. making you feel a loss of self-control
in your life?
0
1
2
3
4
5
19. making you worry?
0
1
2
3
4
5
20. making it difficult for you to concentrate
or remember things?
0
1
2
3
4
5
21. making you feel depressed?
0
1
2
3
4
5
_________________________________________________________________________
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LIVING WITH HEART FAILURE® is a registered trademark of the Regents of the University of Minnesota.
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Minnesota Living with Heart Failure Questionnaire Permission for Use
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Minnesota Living with Heart Failure Questionnaire Permission for Use

Appendix H2
Minnesota Living with Heart Failure Questionnaire Permission for Use

Appendix H3

67
Minnesota Living with Heart Failure

Appendix H4
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Minnesota Living with Heart Failure

Signature Deleted
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n
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Appendix I1
Heart Failure Diary

Sunday

Weight (lbs):

Weight (lbs)

Weight

Loss (-) OR Gain (+)

Loss

Fluid Intake

No

Weight

-5

-4

-3

-2

-1

0

+1

Lots of

Fluid
Salt Intake

Gain

Fluid

No

Lots of

Salt

Salt

Shortness of Breath

No

Very

(SOB)

SOB

SOB

Swelling

No

Lots of

Swelling
Taking Medication

No

All

Meds

Meds

Monday

Weight (lbs):

Weight (lbs)

Weight

Loss (-) OR Gain (+)

Loss

Fluid Intake

No

Weight

-5

Fluid
Salt Intake

Swelling

-4

-3

-2

-1

0

+1

Gain
Lots of
Fluid

No

Lots of

Salt

Salt

Shortness of Breath

No

Very

(SOB)

SOB

SOB

Swelling

No
Swelling

Taking Medication

Lots of
Swelling

No

All

Meds

Meds
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Appendix I2
Heart Failure Diary

Sunday Weight – Saturday Weight = TOTAL
Total

GAIN (+)

Total

LOSS (-)

NOTES

(gain OR loss)
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Appendix J
Evaluation Form

Strongly

Disagree

Neutral

Disagree

A Patient Guide book used for education
was appropriate
The individual education was informative
I felt comfortable asking questions and
verbalizing concerns
I understand Heart Failure BETTER now
than before participation in the study
The Heart Failure Diary was simple to use
Using a Heart Failure Diary is very
beneficial in keeping track of my weight
and symptoms
I will continue to use the Heart Failure
Diary
All of the forms were easy to read
All of the forms were easy to understand
Participating in the study made a
difference in how I care for myself
The student researcher was informative
The student researcher was accessible
The student researcher was organized

	
  
	
  
	
  
	
  

Comments:	
  

Strongly
Agree

The Baptist Medical Center Heart Failure:

	
  

Agree
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Appendix K
Heart Failure: A Patient Guide Book

Heart Failure:
A Patient Guidebook
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Appendix L
Master List

Master List
PARTICIPANT CODE #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

NAME

PHONE NUMBER
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